Organic electroluminescent materials and devices

ABSTRACT

A compound, Ir(L A ) m (L B ) 3-m , having a structure of Formula I, 
     
       
         
         
             
             
         
       
     
     is provided. In Formula I, each of moiety A and moiety C is independently a 5- or 6-membered ring or a polycyclic fused ring system comprising 5- or 6-membered rings; moiety B is a 5-membered heterocyclic ring; Z 1 , Z 2 , and Z 3  are C or N; m is 1 or 2; at least one of R 1 , R 2 , R 3 , R 4  has a structure of Formula II, 
     
       
         
         
             
             
         
       
     
     or is a 5-membered heterocyclic ring; each of X 1 , X 2 , X 3 , X 4 , and X 5  is CR or N; each of R 1 , R 2 , R 3 , R 4 , R A , R B , R C , and R is hydrogen or a General Substituent; at least one of R 1a , R 2a , R 3a , R 4a , R 5a  is cycloalkyl, alkyl, silyl, germyl, deuterated variants thereof, fluorinated variants thereof, and combinations thereof. Formulations, OLEDs, and consumer products containing the compound are also provided.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority under 35 U.S.C. § 119(e) to U.S.Provisional Applications No. 63/195,451, filed on Jun. 1, 2021, No.63/178,673, filed on Apr. 23, 2021, No. 63/182,350, filed on Apr. 30,2021, No. 63/214,086, filed on Jun. 23, 2021, the entire contents ofwhich are incorporated herein by reference.

FIELD

The present disclosure generally relates to organometallic compounds andformulations and their various uses including as emitters in devicessuch as organic light emitting diodes and related electronic devices.

BACKGROUND

Opto-electronic devices that make use of organic materials are becomingincreasingly desirable for various reasons. Many of the materials usedto make such devices are relatively inexpensive, so organicopto-electronic devices have the potential for cost advantages overinorganic devices. In addition, the inherent properties of organicmaterials, such as their flexibility, may make them well suited forparticular applications such as fabrication on a flexible substrate.Examples of organic opto-electronic devices include organic lightemitting diodes/devices (OLEDs), organic phototransistors, organicphotovoltaic cells, and organic photodetectors. For OLEDs, the organicmaterials may have performance advantages over conventional materials.

OLEDs make use of thin organic films that emit light when voltage isapplied across the device. OLEDs are becoming an increasinglyinteresting technology for use in applications such as flat paneldisplays, illumination, and backlighting.

One application for phosphorescent emissive molecules is a full colordisplay. Industry standards for such a display call for pixels adaptedto emit particular colors, referred to as “saturated” colors. Inparticular, these standards call for saturated red, green, and bluepixels. Alternatively, the OLED can be designed to emit white light. Inconventional liquid crystal displays emission from a white backlight isfiltered using absorption filters to produce red, green and blueemission. The same technique can also be used with OLEDs. The white OLEDcan be either a single emissive layer (EML) device or a stack structure.Color may be measured using CIE coordinates, which are well known to theart.

SUMMARY

In one aspect, the present disclosure provides a compound,Ir(L_(A))_(m)(L_(B))_(3-m), having a structure of Formula I,

In Formula I:

each of moiety A and moiety C is independently a 5-membered carbocyclicor heterocyclic ring, a 6-membered carbocyclic or heterocyclic ring, ora polycyclic fused ring system comprising 5-membered and/or 6-memberedcarbocyclic or heterocyclic rings;

moiety B is a 5-membered heterocyclic ring;

Z¹, Z², and Z³ are each independently C or N;

m is 1 or 2;

each two L_(A) when m is 2, and two L_(B) when m is 1, can be same ordifferent;

R^(A), R^(B), and R^(C) each independently represents mono to themaximum allowable substitution, or no substitution;

at least one of R¹, R², R³, R⁴ has a structure of Formula II,

or is a 5-membered heterocyclic ring;

X¹ is CR^(1a) or N, X² is CR^(2a) or N, X³ is CR^(3a) or N, X⁴ isCR^(4a) or N, and X⁵ is CR^(5a) or N;

each of R¹, R², R³, R⁴, R^(A), R^(B), R^(C), R^(1a), R^(2a), R^(3a),R^(4a), and R^(5a) is independently hydrogen or a substituent selectedfrom the group consisting of deuterium, halogen, alkyl, cycloalkyl,heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino,germyl, selenyl, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl,aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile,isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinationsthereof;

at least one of R^(1a), R^(2a), R^(3a), R^(4a), R^(5a) is selected fromthe group consisting of cycloalkyl, alkyl, silyl, germyl, partially orfully deuterated variants thereof, partially or fully fluorinatedvariants thereof, and combinations thereof;

if R³ has Formula II, R^(3a) is alkyl, and each of R^(1a), R^(2a),R^(4a), and R^(5a)is H, then R^(3a) is partially or fully deuterated orR^(3a) comprises at least four carbon atoms; and

wherein any two substituents may be joined or fused to form a ring, withthe provisos that R^(1a), R^(2a), R^(3a), R^(4a), and R^(5a) do not forma 6-membered ring.

In another aspect, the present disclosure provides a formulationcomprising a compound of Formula I as described herein.

In yet another aspect, the present disclosure provides an OLED having anorganic layer comprising a compound of Formula I as described herein.

In yet another aspect, the present disclosure provides a consumerproduct comprising an OLED with an organic layer comprising a compoundof Formula I as described herein.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an organic light emitting device.

FIG. 2 shows an inverted organic light emitting device that does nothave a separate electron transport layer.

DETAILED DESCRIPTION A. Terminology

Unless otherwise specified, the below terms used herein are defined asfollows:

As used herein, the term “organic” includes polymeric materials as wellas small molecule organic materials that may be used to fabricateorganic opto-electronic devices. “Small molecule” refers to any organicmaterial that is not a polymer, and “small molecules” may actually bequite large. Small molecules may include repeat units in somecircumstances. For example, using a long chain alkyl group as asubstituent does not remove a molecule from the “small molecule” class.Small molecules may also be incorporated into polymers, for example as apendent group on a polymer backbone or as a part of the backbone. Smallmolecules may also serve as the core moiety of a dendrimer, whichconsists of a series of chemical shells built on the core moiety. Thecore moiety of a dendrimer may be a fluorescent or phosphorescent smallmolecule emitter. A dendrimer may be a “small molecule,” and it isbelieved that all dendrimers currently used in the field of OLEDs aresmall molecules.

As used herein, “top” means furthest away from the substrate, while“bottom” means closest to the substrate. Where a first layer isdescribed as “disposed over” a second layer, the first layer is disposedfurther away from substrate. There may be other layers between the firstand second layer, unless it is specified that the first layer is “incontact with” the second layer. For example, a cathode may be describedas “disposed over” an anode, even though there are various organiclayers in between.

As used herein, “solution processable” means capable of being dissolved,dispersed, or transported in and/or deposited from a liquid medium,either in solution or suspension form.

A ligand may be referred to as “photoactive” when it is believed thatthe ligand directly contributes to the photoactive properties of anemissive material. A ligand may be referred to as “ancillary” when it isbelieved that the ligand does not contribute to the photoactiveproperties of an emissive material, although an ancillary ligand mayalter the properties of a photoactive ligand.

As used herein, and as would be generally understood by one skilled inthe art, a first “Highest Occupied Molecular Orbital” (HOMO) or “LowestUnoccupied Molecular Orbital” (LUMO) energy level is “greater than” or“higher than” a second HOMO or LUMO energy level if the first energylevel is closer to the vacuum energy level. Since ionization potentials(IP) are measured as a negative energy relative to a vacuum level, ahigher HOMO energy level corresponds to an IP having a smaller absolutevalue (an IP that is less negative). Similarly, a higher LUMO energylevel corresponds to an electron affinity (EA) having a smaller absolutevalue (an EA that is less negative). On a conventional energy leveldiagram, with the vacuum level at the top, the LUMO energy level of amaterial is higher than the HOMO energy level of the same material. A“higher” HOMO or LUMO energy level appears closer to the top of such adiagram than a “lower” HOMO or LUMO energy level.

As used herein, and as would be generally understood by one skilled inthe art, a first work function is “greater than” or “higher than” asecond work function if the first work function has a higher absolutevalue. Because work functions are generally measured as negative numbersrelative to vacuum level, this means that a “higher” work function ismore negative. On a conventional energy level diagram, with the vacuumlevel at the top, a “higher” work function is illustrated as furtheraway from the vacuum level in the downward direction. Thus, thedefinitions of HOMO and LUMO energy levels follow a different conventionthan work functions.

The terms “halo,” “halogen,” and “halide” are used interchangeably andrefer to fluorine, chlorine, bromine, and iodine.

The term “acyl” refers to a substituted carbonyl radical (C(O)—R_(s)).

The term “ester” refers to a substituted oxycarbonyl (—O—C(O)—R_(s) or—C(O)—O—R_(s)) radical.

The term “ether” refers to an —OR_(s) radical.

The terms “sulfanyl” or “thio-ether” are used interchangeably and referto a —SR_(s) radical.

The term “selenyl” refers to a —SeR_(s) radical.

The term “sulfinyl” refers to a —S(O)—R_(s) radical.

The term “sulfonyl” refers to a —SO₂—R_(s) radical.

The term “phosphino” refers to a —P(R_(S))₃ radical, wherein each R_(s)can be same or different.

The term “silyl” refers to a —Si(R_(s))₃ radical, wherein each R_(s) canbe same or different.

The term “germyl” refers to a —Ge(R_(s))₃ radical, wherein each R_(s)can be same or different.

The term “boryl” refers to a —B(R_(s))₂ radical or its Lewis adduct—B(R_(s))₃ radical, wherein R_(s) can be same or different.

In each of the above, R_(s) can be hydrogen or a substituent selectedfrom the group consisting of deuterium, halogen, alkyl, cycloalkyl,heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl,alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, andcombination thereof. Preferred R_(s) is selected from the groupconsisting of alkyl, cycloalkyl, aryl, heteroaryl, and combinationthereof.

The term “alkyl” refers to and includes both straight and branched chainalkyl radicals. Preferred alkyl groups are those containing from one tofifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl,butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl,2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl,2,2-dimethylpropyl, and the like. Additionally, the alkyl group may beoptionally substituted.

The term “cycloalkyl” refers to and includes monocyclic, polycyclic, andspiro alkyl radicals. Preferred cycloalkyl groups are those containing 3to 12 ring carbon atoms and includes cyclopropyl, cyclopentyl,cyclohexyl, bicyclo[3.1.1]heptyl, spiro[4.5]decyl, spiro[5.5]undecyl,adamantyl, and the like. Additionally, the cycloalkyl group may beoptionally substituted.

The terms “heteroalkyl” or “heterocycloalkyl” refer to an alkyl or acycloalkyl radical, respectively, having at least one carbon atomreplaced by a heteroatom. Optionally the at least one heteroatom isselected from O, S, N, P, B, Si and Se, preferably, O, S or N.Additionally, the heteroalkyl or heterocycloalkyl group may beoptionally substituted.

The term “alkenyl” refers to and includes both straight and branchedchain alkene radicals. Alkenyl groups are essentially alkyl groups thatinclude at least one carbon-carbon double bond in the alkyl chain.Cycloalkenyl groups are essentially cycloalkyl groups that include atleast one carbon-carbon double bond in the cycloalkyl ring. The term“heteroalkenyl” as used herein refers to an alkenyl radical having atleast one carbon atom replaced by a heteroatom. Optionally the at leastone heteroatom is selected from O, S, N, P, B, Si, and Se, preferably,O, S, or N. Preferred alkenyl, cycloalkenyl, or heteroalkenyl groups arethose containing two to fifteen carbon atoms. Additionally, the alkenyl,cycloalkenyl, or heteroalkenyl group may be optionally substituted.

The term “alkynyl” refers to and includes both straight and branchedchain alkyne radicals. Alkynyl groups are essentially alkyl groups thatinclude at least one carbon-carbon triple bond in the alkyl chainPreferred alkynyl groups are those containing two to fifteen carbonatoms. Additionally, the alkynyl group may be optionally substituted.

The terms “aralkyl” or “arylalkyl” are used interchangeably and refer toan alkyl group that is substituted with an aryl group. Additionally, thearalkyl group may be optionally substituted.

The term “heterocyclic group” refers to and includes aromatic andnon-aromatic cyclic radicals containing at least one heteroatom.Optionally the at least one heteroatom is selected from O, S, N, P, B,Si, and Se, preferably, O, S, or N. Hetero-aromatic cyclic radicals maybe used interchangeably with heteroaryl. Preferred hetero-non-aromaticcyclic groups are those containing 3 to 7 ring atoms which includes atleast one hetero atom, and includes cyclic amines such as morpholino,piperidino, pyrrolidino, and the like, and cyclic ethers/thio-ethers,such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene, and thelike. Additionally, the heterocyclic group may be optionallysubstituted.

The term “aryl” refers to and includes both single-ring aromatichydrocarbyl groups and polycyclic aromatic ring systems. The polycyclicrings may have two or more rings in which two carbons are common to twoadjoining rings (the rings are “fused”) wherein at least one of therings is an aromatic hydrocarbyl group, e.g., the other rings can becycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls.Preferred aryl groups are those containing six to thirty carbon atoms,preferably six to twenty carbon atoms, more preferably six to twelvecarbon atoms. Especially preferred is an aryl group having six carbons,ten carbons or twelve carbons. Suitable aryl groups include phenyl,biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene,anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene,perylene, and azulene, preferably phenyl, biphenyl, triphenyl,triphenylene, fluorene, and naphthalene. Additionally, the aryl groupmay be optionally substituted.

The term “heteroaryl” refers to and includes both single-ring aromaticgroups and polycyclic aromatic ring systems that include at least oneheteroatom. The heteroatoms include, but are not limited to O, S, N, P,B, Si, and Se. In many instances, O, S, or N are the preferredheteroatoms. Hetero-single ring aromatic systems are preferably singlerings with 5 or 6 ring atoms, and the ring can have from one to sixheteroatoms. The hetero-polycyclic ring systems can have two or morerings in which two atoms are common to two adjoining rings (the ringsare “fused”) wherein at least one of the rings is a heteroaryl, e.g.,the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles,and/or heteroaryls. The hetero-polycyclic aromatic ring systems can havefrom one to six heteroatoms per ring of the polycyclic aromatic ringsystem. Preferred heteroaryl groups are those containing three to thirtycarbon atoms, preferably three to twenty carbon atoms, more preferablythree to twelve carbon atoms. Suitable heteroaryl groups includedibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene,benzofuran, benzothiophene, benzoselenophene, carbazole,indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole,triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole,thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine,oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole,indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline,isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine,phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine,phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine,thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine,preferably dibenzothiophene, dibenzofuran, dibenzoselenophene,carbazole, indolocarbazole, imidazole, pyridine, triazine,benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine,and aza-analogs thereof. Additionally, the heteroaryl group may beoptionally substituted.

Of the aryl and heteroaryl groups listed above, the groups oftriphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran,dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine,pyrazine, pyrimidine, triazine, and benzimidazole, and the respectiveaza-analogs of each thereof are of particular interest.

The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl,cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclic group, aryl,and heteroaryl, as used herein, are independently unsubstituted, orindependently substituted, with one or more general substituents.

In many instances, the general substituents are selected from the groupconsisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl,heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl,boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl,acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl,sulfinyl, sulfonyl, phosphino, boryl, selenyl, and combinations thereof.

In some instances, the preferred general substituents are selected fromthe group consisting of deuterium, fluorine, alkyl, cycloalkyl,heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl,cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile,sulfanyl, boryl, and combinations thereof.

In some instances, the more preferred general substituents are selectedfrom the group consisting of deuterium, fluorine, alkyl, cycloalkyl,alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, sulfanyl, andcombinations thereof.

In yet other instances, the most preferred general substituents areselected from the group consisting of deuterium, fluorine, alkyl,cycloalkyl, aryl, heteroaryl, and combinations thereof.

The terms “substituted” and “substitution” refer to a substituent otherthan H that is bonded to the relevant position, e.g., a carbon ornitrogen. For example, when R¹ represents mono-substitution, then one R¹must be other than H (i.e., a substitution). Similarly, when R¹represents di-substitution, then two of R¹ must be other than H.Similarly, when R¹ represents zero or no substitution, for example, canbe a hydrogen for available valencies of ring atoms, as in carbon atomsfor benzene and the nitrogen atom in pyrrole, or simply representsnothing for ring atoms with fully filled valencies, e.g., the nitrogenatom in pyridine. The maximum number of substitutions possible in a ringstructure will depend on the total number of available valencies in thering atoms.

As used herein, “combinations thereof” indicates that one or moremembers of the applicable list are combined to form a known orchemically stable arrangement that one of ordinary skill in the art canenvision from the applicable list. For example, an alkyl and deuteriumcan be combined to form a partial or fully deuterated alkyl group; ahalogen and alkyl can be combined to form a halogenated alkylsubstituent; and a halogen, alkyl, and aryl can be combined to form ahalogenated arylalkyl. In one instance, the term substitution includes acombination of two to four of the listed groups. In another instance,the term substitution includes a combination of two to three groups. Inyet another instance, the term substitution includes a combination oftwo groups. Preferred combinations of substituent groups are those thatcontain up to fifty atoms that are not hydrogen or deuterium, or thosewhich include up to forty atoms that are not hydrogen or deuterium, orthose that include up to thirty atoms that are not hydrogen ordeuterium. In many instances, a preferred combination of substituentgroups will include up to twenty atoms that are not hydrogen ordeuterium.

The “aza” designation in the fragments described herein, i.e.aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more ofthe C—H groups in the respective aromatic ring can be replaced by anitrogen atom, for example, and without any limitation, azatriphenyleneencompasses both dibenzo[fh]quinoxaline and dibenzo[f,h]quinoline. Oneof ordinary skill in the art can readily envision other nitrogen analogsof the aza-derivatives described above, and all such analogs areintended to be encompassed by the terms as set forth herein.

As used herein, “deuterium” refers to an isotope of hydrogen. Deuteratedcompounds can be readily prepared using methods known in the art. Forexample, U.S. Pat. No. 8,557,400, Patent Pub. No. WO 2006/095951, andU.S. Pat. Application Pub. No. US 2011/0037057, which are herebyincorporated by reference in their entireties, describe the making ofdeuterium-substituted organometallic complexes. Further reference ismade to Ming Yan, et al., Tetrahedron 2015, 71, 1425-30 and Atzrodt etal., Angew. Chem. Int. Ed. (Reviews) 2007, 46, 7744-65, which areincorporated by reference in their entireties, describe the deuterationof the methylene hydrogens in benzyl amines and efficient pathways toreplace aromatic ring hydrogens with deuterium, respectively.

It is to be understood that when a molecular fragment is described asbeing a substituent or otherwise attached to another moiety, its namemay be written as if it were a fragment (e.g. phenyl, phenylene,naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g.benzene, naphthalene, dibenzofuran). As used herein, these differentways of designating a substituent or attached fragment are considered tobe equivalent.

In some instance, a pair of adjacent substituents can be optionallyjoined or fused into a ring. The preferred ring is a five, six, orseven-membered carbocyclic or heterocyclic ring, includes both instanceswhere the portion of the ring formed by the pair of substituents issaturated and where the portion of the ring formed by the pair ofsubstituents is unsaturated. As used herein, “adjacent” means that thetwo substituents involved can be on the same ring next to each other, oron two neighboring rings having the two closest available substitutablepositions, such as 2, 2′ positions in a biphenyl, or 1, 8 position in anaphthalene, as long as they can form a stable fused ring system.

B. The Compounds of the Present Disclosure

In one aspect, the present disclosure provides a compound,Ir(L_(A))_(m)(L_(B))_(3-m), having a structure of Formula I,

In Formula I:

each of moiety A and moiety C is independently a 5-membered carbocyclicor heterocyclic ring, a 6-membered carbocyclic or heterocyclic ring, ora polycyclic fused ring system comprising 5-membered and/or 6-memberedcarbocyclic or heterocyclic rings;

moiety B is a 5-membered heterocyclic ring;

Z¹, Z², and Z³ are each independently C or N;

m is 1 or 2;

each two L_(A) when m is 2, and two L_(B) when m is 1, can be same ordifferent;

R^(A), R^(B), and R^(C) each independently represents mono to themaximum allowable substitution, or no substitution;

at least one of R¹, R², R³, R⁴ has a structure of Formula II,

or is a 5-membered heterocyclic ring;

X¹ is CR^(1a) or N, X² is CR^(2a) or N, X³ is CR^(3a) or N, X⁴ isCR^(4a) or N, and X⁵ is CR^(5a) or N;

each of R¹, R², R³, R⁴, R^(A), R^(B), R^(C), R^(1a), R^(2a), R^(3a),R^(4a), and R^(5a) is independently hydrogen or a substituent selectedfrom the group consisting of the general substituents defined herein;

at least one of R^(1a), R^(2a), R^(3a), R^(4a), R^(5a) is selected fromthe group consisting of cycloalkyl, alkyl, silyl, germyl, partially orfully deuterated variants thereof, partially or fully fluorinatedvariants thereof, and combinations thereof;

if R³ has Formula II, R^(3a) is alkyl, and each of R^(1a), R^(2a),R^(4a), and R^(5a) is H, then R^(3a) is partially or fully deuterated orR^(3a) comprises at least four carbon atoms; and

wherein any two substituents may be joined or fused to form a ring, withthe provisos that R^(1a), R^(2a), R^(3a), R^(4a), and R^(5a) do not forma 6-membered ring.

In some embodiments, each of R¹, R², R³, R⁴, R^(A), R^(B), R^(C),R^(1a), R^(2a), R^(3a), R^(4a), and R^(5a)is independently hydrogen or asubstituent selected from the group consisting of the preferred generalsubstituents defined herein. In some embodiments, each of each of R¹,R², R³, R⁴, R^(A), R^(B), R^(C), R^(1a), R^(2a), R^(3a), R^(4a), andR_(5a) is independently hydrogen or a substituent selected from thegroup consisting of the more preferred general substituents definedherein. In some embodiments, each of each of R¹, R², R³, R⁴, R^(A),R^(B), R^(C), R^(1a), R^(2a), R^(3a), R^(4a), and R^(5a) isindependently hydrogen or a substituent selected from the groupconsisting of the most preferred general substituents defined herein.

In some embodiments, no two R^(A) are joined or fused to form a ring. Insome embodiments, no two R^(C) are joined or fused to form a ring.

In some embodiments, each moiety A and moiety C is independently a5-membered and/or 6-membered carbocyclic or heterocyclic ring. In someembodiments, each moiety A and moiety C is independently benzene,pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole,pyrazole, pyrrole, oxazole, furan, thiophene, or thiazole. In someembodiments, each moiety A and moiety C is independently benzene orpyridine.

In some embodiments, each moiety A and moiety C is independently apolycyclic fused ring system comprising a total of at least two5-membered and/or 6-membered carbocyclic or heterocyclic rings. In someembodiments, each moiety A and moiety C is independently a polycyclicfused ring system comprising a total of at least three 5-membered and/or6-membered carbocyclic or heterocyclic rings. In some embodiments, eachmoiety A and moiety C is independently a polycyclic fused ring systemcomprising a total of at least four 5-membered and/or 6-memberedcarbocyclic or heterocyclic rings. In some embodiments, each moiety Aand moiety C is independently a polycyclic fused ring system comprisinga total of at least one 5-membered carbocyclic or heterocyclic ring andat least two 6-membered carbocyclic or heterocyclic rings.

In some embodiments, each moiety A and moiety C independently comprisesa first ring coordinated to Ir, wherein the first ring is a 6-memberedring; a second ring fused to the first ring, wherein the second ring isa 5-membered ring; and a third ring fused to the second ring, whereinthe third ring is a 6-membered ring.

In some embodiments, each moiety A and moiety C is independentlyselected from the group consisting of naphthalene, quinoline,isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene,benzothiazole, benzoselenophene, indene, indole, benzimidazole,carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine,phenanthrene, phenanthridine, and fluorene.

In some embodiments, each moiety A and moiety C is independently an azaversion of the fused rings as described above. In some such embodiments,each moiety A and moiety C independently contains exact one aza N atom.In some such embodiments, each moiety A and moiety C contains exact twoaza N atoms, which can be in one ring, or in two different rings. Insome such embodiments, the ring having aza N atom is at least separatedby another two rings from the Ir atom. In some such embodiments, thering having aza N atom is at least separated by another three rings fromthe Ir atom. In some such embodiments, each of the ortho position of theaza N atom is substituted.

In some embodiments, at least one R^(A) is selected from the groupconsisting of the Preferred General Substituents defined herein. In someembodiments, at least one R^(A) is on the last fused ring(s) away fromthe Ir atom. In some embodiments, at least one R^(C) is selected fromthe group consisting of the Preferred General Substituents definedherein. In some embodiments, at least one R^(C) is on the last fusedring(s) away from the Ir atom.

In some embodiments, moiety B is imidazole and Z¹ is N. In some suchembodiments, the N of the imidazole moiety not coordinated to Ir issubstituted by aryl, aryl-substituted aryl, or alkyl-substituted aryl,which can be partially or fully deuterated. In some such embodiments,the substitution is on the one or both of the ortho positions of thecarbon atom which is attached to the N of the imidazole moiety notcoordinated to Ir.

In some embodiments, moiety B is carbene and Z¹ is carbene carbon. Insome such embodiments, the carbene ring is a 5-membered or 6-memberedring. In some such embodiments, moiety B is an imidazole-derivedcarbene. In some such embodiments, moiety B is a pyrimidine-derivedcarbene.

In some embodiments, two R^(B) are joined or fused to form a 5-memberedand/or 6-membered carbocyclic or heterocyclic ring. In some embodiments,two R^(B) are joined or fused to form a 5-membered and/or 6-memberedaryl or heteroaryl ring. In some embodiments, two R^(B) are joined orfused to form a benzene, pyridine, pyrimidine, pyridazine, pyrazine,triazine, imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, orthiazole group, which is fused to moiety B, and can be furthersubstituted or fused. In some embodiments, two R^(B) are joined or fusedto form a benzo ring fused to moiety B.

In some embodiments, R¹ is a 5-membered heterocyclic ring. In someembodiments, R² is a 5-membered heterocyclic ring. In some embodiments,R³ is a 5-membered heterocyclic ring. In some embodiments, R⁴ is a5-membered heterocyclic ring. In some embodiments, exactly one of R¹,R², R³, and R⁴ is a 5-membered heterocyclic ring.

In some embodiments, R¹ has a structure of Formula II. In someembodiments, R² has a structure of Formula II. In some embodiments, R³has a structure of Formula II. In some embodiments, R⁴ has a structureof Formula II. In some embodiments, exactly one of R¹, R², R³, and R⁴has a structure of Formula II. In some embodiments, more than one of R¹,R², R³, R⁴ has a structure of Formula II or is a 5-membered heterocyclicring;

In some embodiments, R^(1a) is selected from the group consisting ofcycloalkyl, alkyl, silyl, germyl, partially or fully deuterated variantsthereof, partially or fully fluorinated variants thereof, andcombinations thereof. In some embodiments, R^(1a) comprises at least 3carbon atoms. In some embodiments, R^(1a) comprises at least 4 carbonatoms. In some embodiments, R^(1a) comprises at least 5 carbon atoms.

In some embodiments, R^(2a) is selected from the group consisting ofcycloalkyl, alkyl, silyl, germyl, partially or fully deuterated variantsthereof, partially or fully fluorinated variants thereof, andcombinations thereof. In some embodiments, R^(2a) comprises at least 3carbon atoms. In some embodiments, R^(2a) comprises at least 4 carbonatoms. In some embodiments, R^(2a) comprises at least 5 carbon atoms.

In some embodiments, R^(3a) is selected from the group consisting ofcycloalkyl, alkyl, silyl, germyl, partially or fully deuterated variantsthereof, partially or fully fluorinated variants thereof, andcombinations thereof. In some embodiments, R^(3a) comprises at least 3carbon atoms. In some embodiments, R^(3a) comprises at least 4 carbonatoms. In some embodiments, R^(3a) comprises at least 5 carbon atoms.

In some embodiments, R^(4a) is selected from the group consisting ofcycloalkyl, alkyl, silyl, germyl, partially or fully deuterated variantsthereof, partially or fully fluorinated variants thereof, andcombinations thereof. In some embodiments, R^(4a) comprises at least 3carbon atoms. In some embodiments, R^(4a) comprises at least 4 carbonatoms. In some embodiments, R^(4a) comprises at least 5 carbon atoms.

In some embodiments, R^(5a) is selected from the group consisting ofcycloalkyl, alkyl, silyl, germyl, partially or fully deuterated variantsthereof, partially or fully fluorinated variants thereof, andcombinations thereof. In some embodiments, R^(5a) comprises at least 3carbon atoms. In some embodiments, R^(5a) comprises at least 4 carbonatoms. In some embodiments, R^(5a) comprises at least 5 carbon atoms.

In some embodiments, none of X¹ to X⁵ are N.

In some embodiments, at least one of X¹ to X⁵ is N.

In some embodiments, exactly one of X¹ to X⁵ is N.

In some embodiments, R^(1a) and R^(5a) are hydrogen.

In some embodiments, at least two of R^(1a) to R^(5a) are selected fromthe group consisting of cycloalkyl, alkyl, silyl, germyl, partially orfully deuterated variants thereof, partially or fully fluorinatedvariants thereof, and combinations thereof.

In some embodiments, R³ has a structure of Formula II and R^(3a) isselected from the group consisting of cycloalkyl, alkyl, silyl, andgermyl.

In some embodiments, R^(B) is selected from the group consisting ofaryl, alkyl, and combinations thereof. In some embodiments, R^(B) isselected from the group consisting of 1,6-diarylphenyl and1,6-dialkylphenyl.

In some embodiments, moiety B is imidazole, Z³ is N, and R^(B) attachedto the second imidazole N is selected from the group consisting of1,6-diarylphenyl and 1,6-dialkylphenyl.

In some embodiments, at least one of R^(1a), R^(2a), R^(3a), R^(4a), andR^(5a) is independently hydrogen or a substituent selected from thegroup consisting of the structures of the following LIST 1:

In some embodiments, at least two of R^(1a), R^(2a), R^(3a), R^(4a), andR^(5a) are independently selected from the group consisting of thestructures of LIST 1.

In some embodiments, moiety C is selected from the group consisting ofbenzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine,imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole,naphthalene, quinoline, isoquinoline, quinazoline, benzofuran,benzoxazole, benzothiophene, benzothiazole, benzoselenophene, indene,indole, benzimidazole, carbazole, dibenzofuran, dibenzothiophene,quinoxaline, phthalazine, phenanthrene, phenanthridine, and fluorene.

In some embodiments, ligand L_(A) is selected from the group consistingof:

where ring B1 is a 5-membered or 6-membered aryl or heteroaryl group;

R^(B1) represents mono to the maximum allowable substitution, or nosubstitution;

each R^(B1) and R^(B2) is independently hydrogen or a substituentselected from the group consisting of the General Substituents definedherein;

moiety C is selected from the group consisting of benzene, pyridine,pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole,pyrrole, oxazole, furan, thiophene, thiazole, naphthalene, quinoline,isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene,benzothiazole, benzoselenophene, indene, indole, benzimidazole,carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine,phenanthrene, phenanthridine, and fluorene; and

and two adjacent R^(B), R^(B1), or R^(C) can be joined to form a ring.

In some embodiments, B1 is selected from the group consisting ofbenzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine,imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, and thiazole.In some embodiments, R^(B2) is selected from the group consisting ofalkyl, cycloalkyl, aryl, heteroaryl, their partially or fully deuteratedor partially or fully fluorinated counterparts, and combinationsthereof.

In some embodiments, the ligand L_(A) is selected from the groupconsisting of

where ring B1 is selected from the group consisting of benzene,pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole,pyrazole, pyrrole, oxazole, furan, thiophene, and thiazole; and R^(B2)is selected from the group consisting of alkyl, cycloalkyl, aryl,heteroaryl, their partially or fully deuterated or partially or fullyfluorinated counterparts, and combinations thereof.

In some embodiments, the ligand L_(A) is selected from the groupconsisting of

wherein X¹⁰, X¹¹, X¹², X¹³, X¹⁴, X¹⁵, X¹⁶, X¹⁷, X¹⁸, and X¹⁹ are eachindependently C or N; Y¹⁰⁰ for each occurrence is independently selectedfrom the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO₂, CRR′,SiRR′, and GeRR′; ring B1 is selected from the group consisting ofbenzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine,imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, and thiazole;and R^(B2) is selected from the group consisting of alkyl, cycloalkyl,aryl, heteroaryl, their partially or fully deuterated or partially orfully fluorinated counterparts, and combinations thereof; R^(C1)represents mono to the maximum allowable substitution, or nosubstitution; each R^(C1) is independently hydrogen or a substituentselected from the group consisting of the General Substituents definedherein;

R, and R′ are each independently hydrogen or a substituent selected fromthe group consisting of the General Substituents defined herein; and twoadjacent R^(B), R^(B1), or R^(C1) can be joined to form a ring.

In some embodiments, ligand L_(A) is L_(Ai), wherein i is an integerfrom 1 to 100, and L_(A1) to L_(A100) have the structures in thefollowing LIST 2:

In some embodiments, ligand L_(B) is selected from the group consistingof

where:

R^(2b) and R^(3b) each independently represents mono to the maximumallowable substitution, or no substitution;

Z₁ and Z₂ are each independently C or N;

each of R^(1′), R^(2′), R^(3′), R^(4′), R^(2b), and R^(3b) isindependently hydrogen or a substituent selected from the groupconsisting of the General Substituents defined herein;

moiety A is selected from the group consisting of benzene, pyridine,pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole,pyrrole, oxazole, furan, thiophene, thiazole, naphthalene, quinoline,isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene,benzothiazole, benzoselenophene, indene, indole, benzimidazole,carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine,phenanthrene, phenanthridine, and fluorene; and

two adjacent R^(1′), R^(2′), R^(3′), R^(2b) or R^(3b) can be joined toform a ring.

In some embodiments, two adjacent R^(1′), R^(2′), R^(3′), R^(2b) orR^(3b) are joined to form a fused 5- or 6-membered aromatic ring. Insome embodiments, two adjacent R^(1′), R^(2′), R^(3′), R^(4′), R^(2b) orR^(3b) are joined to form a fused ring selected from the groupconsisting of selected from the group consisting of benzene, pyridine,pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole,pyrrole, oxazole, furan, thiophene, thiazole, naphthalene, quinoline,isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene,benzothiazole, benzoselenophene, indene, indole, benzimidazole,carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine,phenanthrene, phenanthridine, and fluorene.

In some embodiments, the ligand L_(B) is selected from the groupconsisting of

where:

R^(A), R^(A1), R^(2b), and R^(3b) each independently represent mono tothe maximum allowable substitution, or no substitution;

X is selected from the group consisting of BR_(e), NR_(e), PR_(e), O, S,Se, C═O, S═O, SO₂, CR_(e)R_(f), SiR_(e)R_(f), and GeR_(e)R_(f);

each of R^(A), R^(A1), R^(2b), R^(3b), R_(e) and R_(f) is independentlyhydrogen or a substituent selected from the group consisting of thegeneral substituents defined herein; and

two of R^(A), R^(A1), R^(2b), R^(3b), R_(e) and R^(f) can be fused orjoined to form a ring.

In some embodiments, the ligand L_(B) is L_(Bn), wherein n is an integerfrom 1 to 151, and each of L_(B1) to L_(B151) is defined in thefollowing LIST 3:

In some embodiments, the compound has Formula Ir(L_(Ai))(L_(Bn))₂, orFormula Ir(L_(Ai))₂(L_(Bn)), wherein i is an integer from 1 to 100, andn is an integer from 1 to 151, and the structures of L_(A1) to L_(A100)are defined in LIST 2 as defined herein, and structures of L_(B1) toL_(B151) are defined in LIST 3 as defined herein.

In some embodiments, the compound is at least 30% deuterated. In someembodiments, the compound is at least 40% deuterated. In someembodiments, the compound is at least 50% deuterated. In someembodiments, the compound is at least 60% deuterated. In someembodiments, the compound is at least 70% deuterated. In someembodiments, the compound is at least 80% deuterated. In someembodiments, the compound is at least 90% deuterated. In someembodiments, the compound is fully deuterated.

In some embodiments, the compound is selected from the group consistingof the structures of the following LIST 4:

In some embodiments, the compound having the structure of Formula Idescribed herein can be at least 30% deuterated, at least 40%deuterated, at least 50% deuterated, at least 60% deuterated, at least70% deuterated, at least 80% deuterated, at least 90% deuterated, atleast 95% deuterated, at least 99% deuterated, or 100% deuterated. Asused herein, percent deuteration has its ordinary meaning and includesthe percent of possible hydrogen atoms (e.g., positions that arehydrogen, deuterium, or halogen) that are replaced by deuterium atoms.

C. The OLEDs and the Devices of the Present Disclosure

In another aspect, the present disclosure also provides an OLED devicecomprising a first organic layer that contains a compound as disclosedin the above compounds section of the present disclosure.

In some embodiments, the first organic layer may comprise a compound ofFormula I defined herein.

In some embodiments, the organic layer may be an emissive layer and thecompound as described herein may be an emissive dopant or a non-emissivedopant.

In some embodiments, the organic layer may further comprise a host,wherein the host comprises a triphenylene containing benzo-fusedthiophene or benzo-fused furan, wherein any substituent in the host isan unfused substituent independently selected from the group consistingof C_(n)H_(2n+1), OC_(n)H_(2n+1), OAr₁, N(C_(n)H_(2n+1))₂, N(Ar₁)(Ar₂),CH═CH—C_(n)H_(2n+1), C≡CC_(n)H_(2n+1), Ar₁, Ar₁—Ar₂, C_(n)H_(2n)—Ar₁, orno substitution, wherein n is from 1 to 10; and wherein Ar₁ and Ar₂ areindependently selected from the group consisting of benzene, biphenyl,naphthalene, triphenylene, carbazole, and heteroaromatic analogsthereof.

In some embodiments, the organic layer may further comprise a host,wherein host comprises at least one chemical group selected from thegroup consisting of triphenylene, carbazole, indolocarbazole,dibenzothiophene, dibenzofuran, dibenzoselenophene,5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole,5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, triazine,aza-triphenylene, aza-cathazole, aza-indolocarbazole,aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene,aza-5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, andaza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

In some embodiments, the host may be selected from the HOST Groupconsisting of:

and combinations thereof.

In some embodiments, the organic layer may further comprise a host,wherein the host comprises a metal complex.

In some embodiments, the emissive layer can comprise two hosts, a firsthost and a second host. In some embodiments, the first host is a holetransporting host, and the second host is an electron transporting host.In some embodiments, the first host and the second host can form anexciplex.

In some embodiments, the compound as described herein may be asensitizer; wherein the device may further comprise an acceptor; andwherein the acceptor may be selected from the group consisting offluorescent emitter, delayed fluorescence emitter, and combinationthereof.

In yet another aspect, the OLED of the present disclosure may alsocomprise an emissive region containing a compound as disclosed in theabove compounds section of the present disclosure.

In some embodiments, the emissive region may comprise a compound ofFormula I defined herein.

In some embodiments, at least one of the anode, the cathode, or a newlayer disposed over the organic emissive layer functions as anenhancement layer. The enhancement layer comprises a plasmonic materialexhibiting surface plasmon resonance that non-radiatively couples to theemitter material and transfers excited state energy from the emittermaterial to non-radiative mode of surface plasmon polariton. Theenhancement layer is provided no more than a threshold distance awayfrom the organic emissive layer, wherein the emitter material has atotal non-radiative decay rate constant and a total radiative decay rateconstant due to the presence of the enhancement layer and the thresholddistance is where the total non-radiative decay rate constant is equalto the total radiative decay rate constant. In some embodiments, theOLED further comprises an outcoupling layer. In some embodiments, theoutcoupling layer is disposed over the enhancement layer on the oppositeside of the organic emissive layer. In some embodiments, the outcouplinglayer is disposed on opposite side of the emissive layer from theenhancement layer but still outcouples energy from the surface plasmonmode of the enhancement layer. The outcoupling layer scatters the energyfrom the surface plasmon polaritons. In some embodiments this energy isscattered as photons to free space. In other embodiments, the energy isscattered from the surface plasmon mode into other modes of the devicesuch as but not limited to the organic waveguide mode, the substratemode, or another waveguiding mode. If energy is scattered to thenon-free space mode of the OLED other outcoupling schemes could beincorporated to extract that energy to free space. In some embodiments,one or more intervening layer can be disposed between the enhancementlayer and the outcoupling layer. The examples for interventing layer(s)can be dielectric materials, including organic, inorganic, perovskites,oxides, and may include stacks and/or mixtures of these materials.

The enhancement layer modifies the effective properties of the medium inwhich the emitter material resides resulting in any or all of thefollowing: a decreased rate of emission, a modification of emissionline-shape, a change in emission intensity with angle, a change in thestability of the emitter material, a change in the efficiency of theOLED, and reduced efficiency roll-off of the OLED device. Placement ofthe enhancement layer on the cathode side, anode side, or on both sidesresults in OLED devices which take advantage of any of theabove-mentioned effects. In addition to the specific functional layersmentioned herein and illustrated in the various OLED examples shown inthe figures, the OLEDs according to the present disclosure may includeany of the other functional layers often found in OLEDs.

The enhancement layer can be comprised of plasmonic materials, opticallyactive metamaterials, or hyperbolic metamaterials. As used herein, aplasmonic material is a material in which the real part of thedielectric constant crosses zero in the visible or ultraviolet region ofthe electromagnetic spectrum. In some embodiments, the plasmonicmaterial includes at least one metal. In such embodiments the metal mayinclude at least one of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg,Ga, Rh, Ti, Ru, Pd, In, Bi, Ca alloys or mixtures of these materials,and stacks of these materials. In general, a metamaterial is a mediumcomposed of different materials where the medium as a whole actsdifferently than the sum of its material parts. In particular, we defineoptically active metamaterials as materials which have both negativepermittivity and negative permeability. Hyperbolic metamaterials, on theother hand, are anisotropic media in which the permittivity orpermeability are of different sign for different spatial directions.Optically active metamaterials and hyperbolic metamaterials are strictlydistinguished from many other photonic structures such as DistributedBragg Reflectors (“DBRs”) in that the medium should appear uniform inthe direction of propagation on the length scale of the wavelength oflight. Using terminology that one skilled in the art can understand: thedielectric constant of the metamaterials in the direction of propagationcan be described with the effective medium approximation. Plasmonicmaterials and metamaterials provide methods for controlling thepropagation of light that can enhance OLED performance in a number ofways.

In some embodiments, the enhancement layer is provided as a planarlayer. In other embodiments, the enhancement layer has wavelength-sizedfeatures that are arranged periodically, quasi-periodically, orrandomly, or sub-wavelength-sized features that are arrangedperiodically, quasi-periodically, or randomly. In some embodiments, thewavelength-sized features and the sub-wavelength-sized features havesharp edges.

In some embodiments, the outcoupling layer has wavelength-sized featuresthat are arranged periodically, quasi-periodically, or randomly, orsub-wavelength-sized features that are arranged periodically,quasi-periodically, or randomly. In some embodiments, the outcouplinglayer may be composed of a plurality of nanoparticles and in otherembodiments the outcoupling layer is composed of a pluraility ofnanoparticles disposed over a material. In these embodiments theoutcoupling may be tunable by at least one of varying a size of theplurality of nanoparticles, varying a shape of the plurality ofnanoparticles, changing a material of the plurality of nanoparticles,adjusting a thickness of the material, changing the refractive index ofthe material or an additional layer disposed on the plurality ofnanoparticles, varying a thickness of the enhancement layer , and/orvarying the material of the enhancement layer. The plurality ofnanoparticles of the device may be formed from at least one of metal,dielectric material, semiconductor materials, an alloy of metal, amixture of dielectric materials, a stack or layering of one or morematerials, and/or a core of one type of material and that is coated witha shell of a different type of material. In some embodiments, theoutcoupling layer is composed of at least metal nanoparticles whereinthe metal is selected from the group consisting of Ag, Al, Au, Ir, Pt,Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca, alloys ormixtures of these materials, and stacks of these materials. Theplurality of nanoparticles may have additional layer disposed over them.In some embodiments, the polarization of the emission can be tuned usingthe outcoupling layer. Varying the dimensionality and periodicity of theoutcoupling layer can select a type of polarization that ispreferentially outcoupled to air. In some embodiments the outcouplinglayer also acts as an electrode of the device.

In yet another aspect, the present disclosure also provides a consumerproduct comprising an organic light-emitting device (OLED) having ananode; a cathode; and an organic layer disposed between the anode andthe cathode, wherein the organic layer may comprise a compound asdisclosed in the above compounds section of the present disclosure.

In some embodiments, the consumer product comprises an organiclight-emitting device (OLED) having an anode; a cathode; and an organiclayer disposed between the anode and the cathode, wherein the organiclayer may comprise a compound of Formula I defined herein.

In some embodiments, the consumer product can be one of a flat paneldisplay, a computer monitor, a medical monitor, a television, abillboard, a light for interior or exterior illumination and/orsignaling, a heads-up display, a fully or partially transparent display,a flexible display, a laser printer, a telephone, a cell phone, tablet,a phablet, a personal digital assistant (PDA), a wearable device, alaptop computer, a digital camera, a camcorder, a viewfinder, amicro-display that is less than 2 inches diagonal, a 3-D display, avirtual reality or augmented reality display, a vehicle, a video wallcomprising multiple displays tiled together, a theater or stadiumscreen, a light therapy device, and a sign.

Generally, an OLED comprises at least one organic layer disposed betweenand electrically connected to an anode and a cathode. When a current isapplied, the anode injects holes and the cathode injects electrons intothe organic layer(s). The injected holes and electrons each migratetoward the oppositely charged electrode. When an electron and holelocalize on the same molecule, an “exciton,” which is a localizedelectron-hole pair having an excited energy state, is formed. Light isemitted when the exciton relaxes via a photoemissive mechanism In somecases, the exciton may be localized on an excimer or an exciplex.Non-radiative mechanisms, such as thermal relaxation, may also occur,but are generally considered undesirable.

Several OLED materials and configurations are described in U.S. Pat.Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated hereinby reference in their entirety.

The initial OLEDs used emissive molecules that emitted light from theirsinglet states (“fluorescence”) as disclosed, for example, in U.S. Pat.No. 4,769,292, which is incorporated by reference in its entirety.Fluorescent emission generally occurs in a time frame of less than 10nanoseconds.

More recently, OLEDs having emissive materials that emit light fromtriplet states (“phosphorescence”) have been demonstrated. Baldo et al.,“Highly Efficient Phosphorescent Emission from OrganicElectroluminescent Devices,” Nature, vol. 395, 151-154, 1998;(“Baldo-I”) and Baldo et al., “Very high-efficiency green organiclight-emitting devices based on electrophosphorescence,” Appl. Phys.Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated byreference in their entireties. Phosphorescence is described in moredetail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporatedby reference.

FIG. 1 shows an organic light emitting device 100. The figures are notnecessarily drawn to scale. Device 100 may include a substrate 110, ananode 115, a hole injection layer 120, a hole transport layer 125, anelectron blocking layer 130, an emissive layer 135, a hole blockinglayer 140, an electron transport layer 145, an electron injection layer150, a protective layer 155, a cathode 160, and a barrier layer 170.Cathode 160 is a compound cathode having a first conductive layer 162and a second conductive layer 164. Device 100 may be fabricated bydepositing the layers described, in order. The properties and functionsof these various layers, as well as example materials, are described inmore detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which areincorporated by reference.

More examples for each of these layers are available. For example, aflexible and transparent substrate-anode combination is disclosed inU.S. Pat. No. 5,844,363, which is incorporated by reference in itsentirety. An example of a p-doped hole transport layer is m-MTDATA dopedwith F₄-TCNQ at a molar ratio of 50:1, as disclosed in U.S. PatentApplication Publication No. 2003/0230980, which is incorporated byreference in its entirety. Examples of emissive and host materials aredisclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which isincorporated by reference in its entirety. An example of an n-dopedelectron transport layer is BPhen doped with Li at a molar ratio of 1:1,as disclosed in U.S. Patent Application Publication No. 2003/0230980,which is incorporated by reference in its entirety. U.S. Pat. Nos.5,703,436 and 5,707,745, which are incorporated by reference in theirentireties, disclose examples of cathodes including compound cathodeshaving a thin layer of metal such as Mg:Ag with an overlyingtransparent, electrically-conductive, sputter-deposited ITO layer. Thetheory and use of blocking layers is described in more detail in U.S.Pat. No. 6,097,147 and U.S. Patent Application Publication No.2003/0230980, which are incorporated by reference in their entireties.Examples of injection layers are provided in U.S. Patent ApplicationPublication No. 2004/0174116, which is incorporated by reference in itsentirety. A description of protective layers may be found in U.S. PatentApplication Publication No. 2004/0174116, which is incorporated byreference in its entirety.

FIG. 2 shows an inverted OLED 200. The device includes a substrate 210,a cathode 215, an emissive layer 220, a hole transport layer 225, and ananode 230. Device 200 may be fabricated by depositing the layersdescribed, in order. Because the most common OLED configuration has acathode disposed over the anode, and device 200 has cathode 215 disposedunder anode 230, device 200 may be referred to as an “inverted” OLED.Materials similar to those described with respect to device 100 may beused in the corresponding layers of device 200. FIG. 2 provides oneexample of how some layers may be omitted from the structure of device100.

The simple layered structure illustrated in FIGS. 1 and 2 is provided byway of non-limiting example, and it is understood that embodiments ofthe present disclosure may be used in connection with a wide variety ofother structures. The specific materials and structures described areexemplary in nature, and other materials and structures may be used.Functional OLEDs may be achieved by combining the various layersdescribed in different ways, or layers may be omitted entirely, based ondesign, performance, and cost factors. Other layers not specificallydescribed may also be included. Materials other than those specificallydescribed may be used. Although many of the examples provided hereindescribe various layers as comprising a single material, it isunderstood that combinations of materials, such as a mixture of host anddopant, or more generally a mixture, may be used. Also, the layers mayhave various sublayers. The names given to the various layers herein arenot intended to be strictly limiting. For example, in device 200, holetransport layer 225 transports holes and injects holes into emissivelayer 220, and may be described as a hole transport layer or a holeinjection layer. In one embodiment, an OLED may be described as havingan “organic layer” disposed between a cathode and an anode. This organiclayer may comprise a single layer, or may further comprise multiplelayers of different organic materials as described, for example, withrespect to FIGS. 1 and 2 .

Structures and materials not specifically described may also be used,such as OLEDs comprised of polymeric materials (PLEDs) such as disclosedin U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated byreference in its entirety. By way of further example, OLEDs having asingle organic layer may be used. OLEDs may be stacked, for example asdescribed in U.S. Pat. No. 5,707,745 to Forrest et al, which isincorporated by reference in its entirety. The OLED structure maydeviate from the simple layered structure illustrated in FIGS. 1 and 2 .For example, the substrate may include an angled reflective surface toimprove out-coupling, such as a mesa structure as described in U.S. Pat.No. 6,091,195 to Forrest et al., and/or a pit structure as described inU.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated byreference in their entireties.

Unless otherwise specified, any of the layers of the various embodimentsmay be deposited by any suitable method. For the organic layers,preferred methods include thermal evaporation, ink-jet, such asdescribed in U.S. Pat. Nos. 6,013,982 and 6,087,196, which areincorporated by reference in their entireties, organic vapor phasedeposition (OVPD), such as described in U.S. Pat. No. 6,337,102 toForrest et al., which is incorporated by reference in its entirety, anddeposition by organic vapor jet printing (OVJP, also referred to asorganic vapor jet deposition (OVID)), such as described in U.S. Pat. No.7,431,968, which is incorporated by reference in its entirety. Othersuitable deposition methods include spin coating and other solutionbased processes. Solution based processes are preferably carried out innitrogen or an inert atmosphere. For the other layers, preferred methodsinclude thermal evaporation. Preferred patterning methods includedeposition through a mask, cold welding such as described in U.S. Pat.Nos. 6,294,398 and 6,468,819, which are incorporated by reference intheir entireties, and patterning associated with some of the depositionmethods such as ink jet and organic vapor jet printing (OVJP). Othermethods may also be used. The materials to be deposited may be modifiedto make them compatible with a particular deposition method. Forexample, substituents such as alkyl and aryl groups, branched orunbranched, and preferably containing at least 3 carbons, may be used insmall molecules to enhance their ability to undergo solution processing.Substituents having 20 carbons or more may be used, and 3-20 carbons area preferred range. Materials with asymmetric structures may have bettersolution processability than those having symmetric structures, becauseasymmetric materials may have a lower tendency to recrystallizeDendrimer substituents may be used to enhance the ability of smallmolecules to undergo solution processing.

Devices fabricated in accordance with embodiments of the presentdisclosure may further optionally comprise a barrier layer. One purposeof the barrier layer is to protect the electrodes and organic layersfrom damaging exposure to harmful species in the environment includingmoisture, vapor and/or gases, etc. The barrier layer may be depositedover, under or next to a substrate, an electrode, or over any otherparts of a device including an edge. The barrier layer may comprise asingle layer, or multiple layers. The barrier layer may be formed byvarious known chemical vapor deposition techniques and may includecompositions having a single phase as well as compositions havingmultiple phases. Any suitable material or combination of materials maybe used for the barrier layer. The barrier layer may incorporate aninorganic or an organic compound or both. The preferred barrier layercomprises a mixture of a polymeric material and a non-polymeric materialas described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos.PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporatedby reference in their entireties. To be considered a “mixture”, theaforesaid polymeric and non-polymeric materials comprising the barrierlayer should be deposited under the same reaction conditions and/or atthe same time. The weight ratio of polymeric to non-polymeric materialmay be in the range of 95:5 to 5:95. The polymeric material and thenon-polymeric material may be created from the same precursor material.In one example, the mixture of a polymeric material and a non-polymericmaterial consists essentially of polymeric silicon and inorganicsilicon.

Devices fabricated in accordance with embodiments of the presentdisclosure can be incorporated into a wide variety of electroniccomponent modules (or units) that can be incorporated into a variety ofelectronic products or intermediate components. Examples of suchelectronic products or intermediate components include display screens,lighting devices such as discrete light source devices or lightingpanels, etc. that can be utilized by the end-user product manufacturers.Such electronic component modules can optionally include the drivingelectronics and/or power source(s). Devices fabricated in accordancewith embodiments of the present disclosure can be incorporated into awide variety of consumer products that have one or more of theelectronic component modules (or units) incorporated therein. A consumerproduct comprising an OLED that includes the compound of the presentdisclosure in the organic layer in the OLED is disclosed. Such consumerproducts would include any kind of products that include one or morelight source(s) and/or one or more of some type of visual displays. Someexamples of such consumer products include flat panel displays, curveddisplays, computer monitors, medical monitors, televisions, billboards,lights for interior or exterior illumination and/or signaling, heads-updisplays, fully or partially transparent displays, flexible displays,rollable displays, foldable displays, stretchable displays, laserprinters, telephones, mobile phones, tablets, phablets, personal digitalassistants (PDAs), wearable devices, laptop computers, digital cameras,camcorders, viewfinders, micro-displays (displays that are less than 2inches diagonal), 3-D displays, virtual reality or augmented realitydisplays, vehicles, video walls comprising multiple displays tiledtogether, theater or stadium screen, a light therapy device, and a sign.Various control mechanisms may be used to control devices fabricated inaccordance with the present disclosure, including passive matrix andactive matrix. Many of the devices are intended for use in a temperaturerange comfortable to humans, such as 18 degrees C. to 30 degrees C., andmore preferably at room temperature (20-25° C.), but could be usedoutside this temperature range, for example, from −40 degree C. to +80°C.

More details on OLEDs, and the definitions described above, can be foundin U.S. Pat. No. 7,279,704, which is incorporated herein by reference inits entirety.

The materials and structures described herein may have applications indevices other than OLEDs. For example, other optoelectronic devices suchas organic solar cells and organic photodetectors may employ thematerials and structures. More generally, organic devices, such asorganic transistors, may employ the materials and structures.

In some embodiments, the OLED has one or more characteristics selectedfrom the group consisting of being flexible, being rollable, beingfoldable, being stretchable, and being curved. In some embodiments, theOLED is transparent or semi-transparent. In some embodiments, the OLEDfurther comprises a layer comprising carbon nanotubes.

In some embodiments, the OLED further comprises a layer comprising adelayed fluorescent emitter. In some embodiments, the OLED comprises aRGB pixel arrangement or white plus color filter pixel arrangement. Insome embodiments, the OLED is a mobile device, a hand held device, or awearable device. In some embodiments, the OLED is a display panel havingless than 10 inch diagonal or 50 square inch area. In some embodiments,the OLED is a display panel having at least 10 inch diagonal or 50square inch area. In some embodiments, the OLED is a lighting panel.

In some embodiments, the compound can be an emissive dopant. In someembodiments, the compound can produce emissions via phosphorescence,fluorescence, thermally activated delayed fluorescence, i.e., TADF (alsoreferred to as E-type delayed fluorescence; see, e.g., U.S. applicationSer. No. 15/700,352, which is hereby incorporated by reference in itsentirety), triplet-triplet annihilation, or combinations of theseprocesses. In some embodiments, the emissive dopant can be a racemicmixture, or can be enriched in one enantiomer. In some embodiments, thecompound can be homoleptic (each ligand is the same). In someembodiments, the compound can be heteroleptic (at least one ligand isdifferent from others). When there are more than one ligand coordinatedto a metal, the ligands can all be the same in some embodiments. In someother embodiments, at least one ligand is different from the otherligands In some embodiments, every ligand can be different from eachother. This is also true in embodiments where a ligand being coordinatedto a metal can be linked with other ligands being coordinated to thatmetal to form a tridentate, tetradentate, pentadentate, or hexadentateligands Thus, where the coordinating ligands are being linked together,all of the ligands can be the same in some embodiments, and at least oneof the ligands being linked can be different from the other ligand(s) insome other embodiments.

In some embodiments, the compound can be used as a phosphorescentsensitizer in an OLED where one or multiple layers in the OLED containsan acceptor in the form of one or more fluorescent and/or delayedfluorescence emitters. In some embodiments, the compound can be used asone component of an exciplex to be used as a sensitizer. As aphosphorescent sensitizer, the compound must be capable of energytransfer to the acceptor and the acceptor will emit the energy orfurther transfer energy to a final emitter. The acceptor concentrationscan range from 0.001% to 100%. The acceptor could be in either the samelayer as the phosphorescent sensitizer or in one or more differentlayers. In some embodiments, the acceptor is a TADF emitter. In someembodiments, the acceptor is a fluorescent emitter. In some embodiments,the emission can arise from any or all of the sensitizer, acceptor, andfinal emitter.

According to another aspect, a formulation comprising the compounddescribed herein is also disclosed.

The OLED disclosed herein can be incorporated into one or more of aconsumer product, an electronic component module, and a lighting panel.The organic layer can be an emissive layer and the compound can be anemissive dopant in some embodiments, while the compound can be anon-emissive dopant in other embodiments.

In yet another aspect of the present disclosure, a formulation thatcomprises the novel compound disclosed herein is described. Theformulation can include one or more components selected from the groupconsisting of a solvent, a host, a hole injection material, holetransport material, electron blocking material, hole blocking material,and an electron transport material, disclosed herein.

The present disclosure encompasses any chemical structure comprising thenovel compound of the present disclosure, or a monovalent or polyvalentvariant thereof. In other words, the inventive compound, or a monovalentor polyvalent variant thereof, can be a part of a larger chemicalstructure. Such chemical structure can be selected from the groupconsisting of a monomer, a polymer, a macromolecule, and a supramolecule(also known as supermolecule). As used herein, a “monovalent variant ofa compound” refers to a moiety that is identical to the compound exceptthat one hydrogen has been removed and replaced with a bond to the restof the chemical structure. As used herein, a “polyvalent variant of acompound” refers to a moiety that is identical to the compound exceptthat more than one hydrogen has been removed and replaced with a bond orbonds to the rest of the chemical structure. In the instance of asupramolecule, the inventive compound can also be incorporated into thesupramolecule complex without covalent bonds.

D. Combination of the Compounds of the Present Disclosure with OtherMaterials

The materials described herein as useful for a particular layer in anorganic light emitting device may be used in combination with a widevariety of other materials present in the device. For example, emissivedopants disclosed herein may be used in conjunction with a wide varietyof hosts, transport layers, blocking layers, injection layers,electrodes and other layers that may be present. The materials describedor referred to below are non-limiting examples of materials that may beuseful in combination with the compounds disclosed herein, and one ofskill in the art can readily consult the literature to identify othermaterials that may be useful in combination.

a) Conductivity Dopants:

A charge transport layer can be doped with conductivity dopants tosubstantially alter its density of charge carriers, which will in turnalter its conductivity. The conductivity is increased by generatingcharge carriers in the matrix material, and depending on the type ofdopant, a change in the Fermi level of the semiconductor may also beachieved. Hole-transporting layer can be doped by p-type conductivitydopants and n-type conductivity dopants are used in theelectron-transporting layer.

Non-limiting examples of the conductivity dopants that may be used in anOLED in combination with materials disclosed herein are exemplifiedbelow together with references that disclose those materials:EP01617493, EP01968131, EP2020694, EP2684932, US20050139810,US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455,WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804,US20150123047, and US2012146012.

b) HIL/HTL:

A hole injecting/transporting material to be used in the presentdisclosure is not particularly limited, and any compound may be used aslong as the compound is typically used as a hole injecting/transportingmaterial. Examples of the material include, but are not limited to: aphthalocyanine or porphyrin derivative; an aromatic amine derivative; anindolocarbazole derivative; a polymer containing fluorohydrocarbon; apolymer with conductivity dopants; a conducting polymer, such asPEDOT/PSS; a self-assembly monomer derived from compounds such asphosphoric acid and silane derivatives; a metal oxide derivative, suchas MoO_(x); a p-type semiconducting organic compound, such as1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and across-linkable compounds.

Examples of aromatic amine derivatives used in HIL or HTL include, butnot limit to the following general structures:

Each of Ar¹ to Ar⁹ is selected from the group consisting of aromatichydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl,triphenylene, naphthalene, anthracene, phenalene, phenanthrene,fluorene, pyrene, chrysene, perylene, and azulene; the group consistingof aromatic heterocyclic compounds such as dibenzothiophene,dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran,benzothiophene, benzoselenophene, carbazole, indolocarbazole,pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole,oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole,pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine,oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine,benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline,cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine,pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine,benzofuropyridine, furodipyridine, benzothienopyridine,thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine;and the group consisting of 2 to 10 cyclic structural units which aregroups of the same type or different types selected from the aromatichydrocarbon cyclic group and the aromatic heterocyclic group and arebonded to each other directly or via at least one of oxygen atom,nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom,chain structural unit and the aliphatic cyclic group. Each Ar may beunsubstituted or may be substituted by a substituent selected from thegroup consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl,heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl,cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylicacids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl,phosphino, and combinations thereof.

In one aspect, Ar¹ to Ar⁹ is independently selected from the groupconsisting of:

wherein k is an integer from 1 to 20; X¹⁰¹ to X¹⁰⁸ is C (including CH)or N; Z¹⁰¹ is NAr¹, O, or S; Ar¹ has the same group defined above.

Examples of metal complexes used in HIL or HTL include, but are notlimited to the following general formula:

wherein Met is a metal, which can have an atomic weight greater than 40;(Y¹⁰¹-Y¹⁰²) is a bidentate ligand, Y¹⁰¹ and Y¹⁰² are independentlyselected from C, N, O, P, and S; L¹⁰¹ is an ancillary ligand; k′ is aninteger value from 1 to the maximum number of ligands that may beattached to the metal; and k′+k″ is the maximum number of ligands thatmay be attached to the metal.

In one aspect, (Y¹⁰¹-Y¹⁰²) is a 2-phenylpyridine derivative. In anotheraspect, (Y¹⁰¹-Y¹⁰²) is a carbene ligand In another aspect, Met isselected from Ir, Pt, Os, and Zn. In a further aspect, the metal complexhas a smallest oxidation potential in solution vs. Fc⁺/Fc couple lessthan about 0.6 V.

Non-limiting examples of the HIL and HTL materials that may be used inan OLED in combination with materials disclosed herein are exemplifiedbelow together with references that disclose those materials:CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334,EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701,EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765,JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473,TW201139402, U.S. Pat. No. 06,517,957, US20020158242, US20030162053,US20050123751, US20060182993, US20060240279, US20070145888,US20070181874, US20070278938, US20080014464, US20080091025,US20080106190, US20080124572, US20080145707, US20080220265,US20080233434, US20080303417, US2008107919, US20090115320,US20090167161, US2009066235, US2011007385, US20110163302, US2011240968,US2011278551, US2012205642, US2013241401, US20140117329, US2014183517,U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550,WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006,WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577,WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937,WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.

c) EBL:

An electron blocking layer (EBL) may be used to reduce the number ofelectrons and/or excitons that leave the emissive layer. The presence ofsuch a blocking layer in a device may result in substantially higherefficiencies, and/or longer lifetime, as compared to a similar devicelacking a blocking layer. Also, a blocking layer may be used to confineemission to a desired region of an OLED. In some embodiments, the EBLmaterial has a higher LUMO (closer to the vacuum level) and/or highertriplet energy than the emitter closest to the EBL interface. In someembodiments, the EBL material has a higher LUMO (closer to the vacuumlevel) and/or higher triplet energy than one or more of the hostsclosest to the EBL interface. In one aspect, the compound used in EBLcontains the same molecule or the same functional groups used as one ofthe hosts described below.

d) Hosts:

The light emitting layer of the organic EL device of the presentdisclosure preferably contains at least a metal complex as lightemitting material, and may contain a host material using the metalcomplex as a dopant material. Examples of the host material are notparticularly limited, and any metal complexes or organic compounds maybe used as long as the triplet energy of the host is larger than that ofthe dopant. Any host material may be used with any dopant so long as thetriplet criteria is satisfied.

Examples of metal complexes used as host are preferred to have thefollowing general formula:

wherein Met is a metal; (Y¹⁰³-Y¹⁰⁴) is a bidentate ligand, Y¹⁰³ and Y¹⁰⁴are independently selected from C, N, O, P, and S; L¹⁰¹ is an anotherligand; k′ is an integer value from 1 to the maximum number of ligandsthat may be attached to the metal; and k′+k″ is the maximum number ofligands that may be attached to the metal.

In one aspect, the metal complexes are:

wherein (O—N) is a bidentate ligand, having metal coordinated to atoms Oand N.

In another aspect, Met is selected from Ir and Pt. In a further aspect,(Y¹⁰³-Y¹⁰⁴) is a carbene ligand

In one aspect, the host compound contains at least one of the followinggroups selected from the group consisting of aromatic hydrocarbon cycliccompounds such as benzene, biphenyl, triphenyl, triphenylene,tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene,fluorene, pyrene, chrysene, perylene, and azulene; the group consistingof aromatic heterocyclic compounds such as dibenzothiophene,dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran,benzothiophene, benzoselenophene, carbazole, indolocarbazole,pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole,oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole,pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine,oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine,benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline,cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine,pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine,benzofuropyridine, furodipyridine, benzothienopyridine,thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine;and the group consisting of 2 to 10 cyclic structural units which aregroups of the same type or different types selected from the aromatichydrocarbon cyclic group and the aromatic heterocyclic group and arebonded to each other directly or via at least one of oxygen atom,nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom,chain structural unit and the aliphatic cyclic group. Each option withineach group may be unsubstituted or may be substituted by a substituentselected from the group consisting of deuterium, halogen, alkyl,cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy,amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl,heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile,sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, the host compound contains at least one of the followinggroups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen,deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl,arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl,heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether,ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, andcombinations thereof, and when it is aryl or heteroaryl, it has thesimilar definition as Ar's mentioned above. k is an integer from 0 to 20or 1 to 20. X¹⁰¹ to X¹⁰⁸ are independently selected from C (includingCH) or N. Z¹⁰¹ and Z¹⁰² are independently selected from NR¹⁰¹, O, or S.

Non-limiting examples of the host materials that may be used in an OLEDin combination with materials disclosed herein are exemplified belowtogether with references that disclose those materials: EP2034538,EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644,KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919,US20060280965, US20090017330, US20090030202, US20090167162,US20090302743, US20090309488, US20100012931, US20100084966,US20100187984, US2010187984, US2012075273, US2012126221, US2013009543,US2013105787, US2013175519, US2014001446, US20140183503, US20140225088,US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207,WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754,WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778,WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423,WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649,WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472,US20170263869, US20160163995, U.S. Pat. No. 9,466,803,

e) Additional Emitters:

One or more additional emitter dopants may be used in conjunction withthe compound of the present disclosure. Examples of the additionalemitter dopants are not particularly limited, and any compounds may beused as long as the compounds are typically used as emitter materials.Examples of suitable emitter materials include, but are not limited to,compounds which can produce emissions via phosphorescence, fluorescence,thermally activated delayed fluorescence, i.e., TADF (also referred toas E-type delayed fluorescence), triplet-triplet annihilation, orcombinations of these processes.

Non-limiting examples of the emitter materials that may be used in anOLED in combination with materials disclosed herein are exemplifiedbelow together with references that disclose those materials:CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526,EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907,EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652,KR20120032054, KR20130043460, TW201332980, U.S. Pat. Nos. 06,699,599,06,916,554, US20010019782, US20020034656, US20030068526, US20030072964,US20030138657, US20050123788, US20050244673, US2005123791, US2005260449,US20060008670, US20060065890, US20060127696, US20060134459,US20060134462, US20060202194, US20060251923, US20070034863,US20070087321, US20070103060, US20070111026, US20070190359,US20070231600, US2007034863, US2007104979, US2007104980, US2007138437,US2007224450, US2007278936, US20080020237, US20080233410, US20080261076,US20080297033, US200805851, US2008161567, US2008210930, US20090039776,US20090108737, US20090115322, US20090179555, US2009085476, US2009104472,US20100090591, US20100148663, US20100244004, US20100295032,US2010102716, US2010105902, US2010244004, US2010270916, US20110057559,US20110108822, US20110204333, US2011215710, US2011227049, US2011285275,US2012292601, US20130146848, US2013033172, US2013165653, US2013181190,US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238,6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915,7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137,7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361,WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981,WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418,WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673,WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089,WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327,WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565,WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456,WO2014112450.

f) HBL:

A hole blocking layer (HBL) may be used to reduce the number of holesand/or excitons that leave the emissive layer. The presence of such ablocking layer in a device may result in substantially higherefficiencies and/or longer lifetime as compared to a similar devicelacking a blocking layer. Also, a blocking layer may be used to confineemission to a desired region of an OLED. In some embodiments, the HBLmaterial has a lower HOMO (further from the vacuum level) and/or highertriplet energy than the emitter closest to the HBL interface. In someembodiments, the HBL material has a lower HOMO (further from the vacuumlevel) and/or higher triplet energy than one or more of the hostsclosest to the HBL interface.

In one aspect, compound used in HBL contains the same molecule or thesame functional groups used as host described above.

In another aspect, compound used in HBL contains at least one of thefollowing groups in the molecule:

wherein k is an integer from 1 to 20; L¹⁰¹ is another ligand, k′ is aninteger from 1 to 3.

g) ETL:

Electron transport layer (ETL) may include a material capable oftransporting electrons. Electron transport layer may be intrinsic(undoped), or doped. Doping may be used to enhance conductivity.Examples of the ETL material are not particularly limited, and any metalcomplexes or organic compounds may be used as long as they are typicallyused to transport electrons.

In one aspect, compound used in ETL contains at least one of thefollowing groups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen,deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl,arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl,heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether,ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, andcombinations thereof, when it is aryl or heteroaryl, it has the similardefinition as Ar's mentioned above. Ar¹ to Ar³ has the similardefinition as Ar's mentioned above. k is an integer from 1 to 20. X¹⁰¹to X¹⁰⁸ is selected from C (including CH) or N.

In another aspect, the metal complexes used in ETL contains, but notlimit to the following general formula:

wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinatedto atoms O, N or N, N; L¹⁰¹ is another ligand; k′ is an integer valuefrom 1 to the maximum number of ligands that may be attached to themetal.

Non-limiting examples of the ETL materials that may be used in an OLEDin combination with materials disclosed herein are exemplified belowtogether with references that disclose those materials: CN103508940,EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918,JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977,US2007018155, US20090101870, US20090115316, US20090140637,US20090179554, US2009218940, US2010108990, US2011156017, US2011210320,US2012193612, US2012214993, US2014014925, US2014014927, US20140284580,U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263,WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373,WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,

h) Charge Generation Layer (CGL)

In tandem or stacked OLEDs, the CGL plays an essential role in theperformance, which is composed of an n-doped layer and a p-doped layerfor injection of electrons and holes, respectively. Electrons and holesare supplied from the CGL and electrodes. The consumed electrons andholes in the CGL are refilled by the electrons and holes injected fromthe cathode and anode, respectively; then, the bipolar currents reach asteady state gradually. Typical CGL materials include n and pconductivity dopants used in the transport layers.

In any above-mentioned compounds used in each layer of the OLED device,the hydrogen atoms can be partially or fully deuterated. The minimumamount of hydrogen of the compound being deuterated is selected from thegroup consisting of 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99%, and100%. Thus, any specifically listed substituent, such as, withoutlimitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partiallydeuterated, and fully deuterated versions thereof. Similarly, classes ofsubstituents such as, without limitation, alkyl, aryl, cycloalkyl,heteroaryl, etc. also may be undeuterated, partially deuterated, andfully deuterated versions thereof.

It is understood that the various embodiments described herein are byway of example only and are not intended to limit the scope of theinvention. For example, many of the materials and structures describedherein may be substituted with other materials and structures withoutdeviating from the spirit of the invention. The present invention asclaimed may therefore include variations from the particular examplesand preferred embodiments described herein, as will be apparent to oneof skill in the art. It is understood that various theories as to whythe invention works are not intended to be limiting.

E. Experimental Section SYNTHESIS EXAMPLE 1

Di-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]diiridium(III)

A mixture of1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl)-1H-benzo[d]imidazole(7 g, 18.21 mmol, 2.2 equiv) and iridium(III) chloride hydrate (2.62 g,8.28 mmol, 1.0 equiv) in 2-ethoxyethanol (90 mL) and DIUF water (30 mL)was heated at 102° C. for 70 hours. The cooled reaction mixture wasfiltered, the solid washed with methanol (3×50 mL) then dried in avacuum oven for a few hours at ˜50° C. to givedi-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imid-azol-3-yl]diiridium(III) (7.08 g, 86% yield) as a yellow solid.

[Ir(1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl)(1H)₂(MeOH)₂]trifluoromethanesulfonate

A solution of silver trifluoromethanesulfonate (1.85 g, 7.21 mmol, 2.2equiv) in methanol (18 mL) was added in one portion to a solution ofdi-μ-chloro-tetra-kis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]diiridium(III) (7 g, 3.26 mmol, 1.0 equiv) in dichloro-methane (90 mL) and theflask wrapped with foil to exclude light. The reaction mixture wasstirred at room temperature overnight under nitrogen. The reactionmixture was filtered through a short pad (˜1 inch) of silica gel,rinsing with dichloromethane (2×100 mL) then a 5:1 mixture ofdichloromethane and methanol (2×100 mL). The filtrate was concentratedunder reduced pressure and the residue dried in a vacuum oven at 50° C.overnight to give[Ir(1-(2,6-bis-(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-(1H)₂(MeOH)₂]trifluoromethanesulfonate (7.9 g, 103% yield) as a yellow-greenishsolid.

Bis[1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]-[(2-(dibenzo[b,d]furan-4-yl)-3′-yl)-4-(4-(2,2-dimethyl-propyl-1,1-d₂)phenyl)pyridin-1-yl)iridium(III)

A mixture of[Ir(1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl)(1H)₂(MeOH)₂]trifluoromethanesulfonate (2.6 g, 2.21 mmol, 1.0 equiv) and2-(dibenzo[b,d]furan-4-yl)-4-(4-(2,2-dimethyl-propyl-1,1-d₂)phenyl)pyridine(0.876 g, 2.21 mmol, 1.0 equiv) in ethanol (40 mL) was heated at 78° C.for 2 hours then 2,6-lutidine (0.237 g, 2.21 mmol, 1.0 equiv) added. Thereaction mixture was heated at 78° C. for 30 hours, cooled to roomtemperature then concentrated under reduced pressure. The residue wasdissolved in toluene (˜20 mL) then loaded on to a Biotage automatedchromatography system (2 stacked 220 g and one 330 g silica gelcartridges), eluting with a gradient of 0-25% toluene in hexanes. Therecovered product (2.2 g, 73% yield) was filtered through basic alumina(450 g), eluting with 50% dichloromethane in hexanes. The recoveredsolid (2.1 g) was dissolved in dichloromethane (40 mL) then precipitatedwith methanol (260 mL) to give bis[1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imid-azol-3-yl]-[(2-(dibenzo[b,d]furan-4-yl)-3′-yl)-4-(4-(2,2-dimethylpropyl-1,1-d₂)-phenyl)pyridin-1-yl)iridium(III)(1.98 g, 99.6% UPLC purity) as a red-orange solid.

SYNTHESIS EXAMPLE 2

Di-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]diiridium(III)

A mixture of1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl)-1H-benzo-[d]imidazole(7 g, 18.21 mmol, 2.2 equiv) and iridium(III) chloride hydrate (2.62 g,8.28 mmol, 1.0 equiv) in 2-ethoxyethanol (90 mL) and water (30 mL) washeated at 102° C. for 70 hours. The cooled reaction mixture wasfiltered, the solid washed with methanol (3×50 mL) then dried in avacuum oven for a few hours at ˜50° C. to givedi-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis-(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imid-azol-3-yl]-diiridium(III) (7.08 g, 86% yield) as a yellow solid.

[Ir(1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo-[d]imidazol-3-yl)(1H)₂(MeOH)₂]trifluoromethanesulfonate

A solution of silver trifluoromethanesulfonate (1.85 g, 7.21 mmol, 2.2equiv) in methanol (18 mL) was added in one portion to a solution ofdi-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]diiridium(III) (7 g, 3.26 mmol, 1.0 equiv) in dichloro-methane (90 mL) and theflask wrapped with foil to exclude light. The reaction mixture wasstirred at room temperature overnight under nitrogen. The reactionmixture was filtered through a short (˜1 inch) pad of silica gel,rinsing with dichloromethane (2×100 mL) then a 5:1 mixture ofdichloromethane and methanol (2×100 mL). The filtrate was concentratedunder reduced pressure and the residue dried in a vacuum oven at 50° C.overnight to give[Ir(1-(2,6-bis-(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl)-(1H)₂(MeOH)₂]trifluoromethanesulfonate (7.9 g, 103% yield) as a yellow-green solid.

Bis[1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo-[d]imidazol-3-yl][4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-(phenyl-2′-yl)pyri-din-1-yl]iridium(III)

A mixture of[Ir(1-(2,6-bis-(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl)-(1H)₂-[MeOH)₂]trifluoromethanesulfonate (2.63 g, 2.24 mmol, 1.0 equiv),4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-phenylpyridine (0.68 g, 2.24mmol, 1.0 equiv) and 2,6-lutidine (0.24 g, 2.24 mmol, 1.0 equiv) inethanol (40 mL) was heated at 78° C. for 40 hours. The cooled reactionmixture was concentrated under reduced pressure. The residue waspurified on a Buchi automated chromatography system (220 g and 330 gstacked silica gel cartridges), eluting with a gradient of 0-20-25%dichloromethane in hexanes. The recovered product (1.7 g, 98% UPLCpurity) was re-purified on a Büchi automated chromatography system (6stacked 120 g silica gel cartridges), eluting with a gradient of0-20-25% dichloromethane in hexanes. The recovered product (1.4 g) wasfiltered through basic alumina (450 g), eluting with 50% dichloromethanein hexanes. The recovered solid (1.3 g) was dissolved in dichloromethane(2 mL) and precipitated with methanol (250 mL). The solid was filteredand dried in a vacuum oven at ˜50° C. overnight to givebis[1-(2,6-bis(pro-pan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl][4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-(phenyl-2′-yl)pyridin-1-yl]iridium(III)(1.25 g, 44% yield, 99.9% UPLC purity) as a red-orange solid.

SYNTHESIS EXAMPLE 3

Di-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]diiridium(III)

A mixture of1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl)-1H-benzo-[d]imidazole(7 g, 18.21 mmol, 2.2 equiv) and iridium(III) chloride hydrate (2.62 g,8.28 mmol, 1.0 equiv), 2-ethoxyethanol (90 mL) and water (30 mL) washeated at 102° C. for 70 hours. The cooled reaction mixture wasfiltered, the solid washed with methanol (3×50 mL) then dried in avacuum oven for a few hours at ˜50° C. to givedi-μ-chloro-tetrakis[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imid-azol-3-yl]diiridium(III) (7.08 g, 86% yield) as a yellow solid.

[Ir(1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo-[d]imidazol-3-yl)(1H)₂(MeOH)₂]trifluoromethanesulfonate

A solution of silver trifluoromethanesulfonate (1.85 g, 7.21 mmol, 2.2equiv) in methanol (18 mL) was added in one portion to a solution ofdi-μ-chloro-tetrakis-[k2(C2,N)-1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl]diiridium(III) (7 g, 3.26 mmol, 1.0 equiv) in dichloro-methane (90 mL) and theflask wrapped with foil to exclude light. The reaction mixture wasstirred at room temperature overnight under nitrogen. The reactionmixture was filtered through a ˜1 inch pad of silica gel, rinsing withdichloro-methane (2×100 mL) then a 5:1 mixture of dichloromethane andmethanol (2×100 mL). The filtrate was concentrated under reducedpressure and the residue dried in a vacuum oven at 50° C. overnight togive[Ir(1-(2,6-bis-(propan-2-yl-d₇)-phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl)-(1H)₂(MeOH)₂]trifluoromethanesulfonate (7.9 g, 103% yield) as a yellow-greenishsolid.

Bis[1-(2,6-bis(propan-2-yl-th)phenyl)-2-(4-(methyl-d₃)phen-2′-yl)-1H-benzo-[d]imidazol-1-yl)-[4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-((naphtho-[1,2-b]benzofuran-10-yl)-4′-yl)pyridin-1-yl]iridium(III)

A 250 mL 4-neck flask was charged withIr(1-(2,6-bis(propan-2-yl-d₇)phenyl)-2-(4-(methyl-d₃)phenyl-2′-yl)-1H-benzo[d]imidazol-3-yl)(1H)₂(MeOH)₂]trifluoro-methane sulfonate (2.50 g, 2.13 mmol, 1.0 equiv),4-(4-(2,2-di-methylpropyl-1,1-d₂)phenyl-2,6-d₂)-2-(naphtho[1,2-b]benzofuran-10-yl)pyridine(0.953 g, 2.13 mmol, 1.0 equiv) and ethanol (106 mL). 2,6-Lutidine(0.247 mL, 2.13 mmol, 1.0 equiv) was added then the reaction mixtureheated at 75° C. After 18.5 hours, the reaction was determined completeby UPLC analysis, with 81% conversion. The cooled reaction mixture wasfiltered and the solid washed with methanol (50 mL). The crude materialwas purified on a Biotage automated chromatography system (2 stacked 350g Biotage silica gel cartridges), eluting with 0-20% tetrahydrofuran inhexanes. Pure fractions were concentrated under reduced pressure. Therecovered product was dissolved in dichloromethane (50 mL), precipitatedwith methanol (100 mL) and the red-orange solids filtered. The recoveredmaterial (98.3% UPLC purity) was re-purified on a Biotage automatedchromatography system (2 stacked 350 g Biotage silica gel cartridges),eluting with 10-50% toluene in hexanes. Pure fractions were concentratedto an orange solid which was precipitated from dichloromethane (50 mL)with methanol (100 mL). The solid was filtered and dried in a vacuumoven overnight at 50° C. to givebis[1-(2,6-bis(propan-2-yl-ch)phenyl)-2-(4-(methyl-d₃)phen-2′-yl)-1H-benzo-[d]imidazol-1-yl][4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-((naphtho[1,2-b]benzofuran-10-yl)-4′-yl)pyridin-1-yl]iridium(III)(1.71 g, 57% yield, 99.9% UPLC purity) as an orange solid.

SYNTHESIS EXAMPLE 4

[Ir(4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phenyl)pyridine(-1H))₂(MeOH)₂]tri-fluoromethanesulfonate

To a solution ofdi-μ-chloro-tetrakis[κ2(C2,N)-4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)-phenyl)pyridine]diiridium(III)(106 g 122 mmol, 1.0 equiv) in dichloromethane (2.0 L), in a flaskwrapped with foil to exclude light, was added a solution of silvertrifluoromethanesulfonate (69.3 g, 270 mmol, 2.2 equiv) in methanol (500mL). The reaction mixture was stirred overnight at room temperatureunder nitrogen. The reaction mixture was filtered through a pad ofsilica gel pad (300 g) topped with Celite® (20 g), rinsing withdichloromethane (1.0 L). The filtrate was concentrated under reducedpressure and the residue dried in a vacuum oven to give[Ir(4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phenyl)pyridine(-1H))₂(MeOH)₂]trifluoromethanesulfonate (˜162.5 g, 81% yield) as a yellow solid.

Mer-Bis[2-(4-(methyl-d₃)phenyl-2′-yl)-4,5-bis(methyl-d₃)pyridin-1-yl][2-((di-benzo[b,d]furan-4-yl)-3′-yl)-4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-pyridin-1-yl]iridium(III)

A nitrogen flushed 500 mL 4-neck flask was charged with[Ir(4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phenyl)-pyridine(-H))₂(MeOH)₂](trifluoromethanesulfonate)(6.5 g, 7.97 mmol, 1.0 equiv) and2-(dibenzo[b,d]furan-4-yl)-4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-pyridine(3.5 g, 8.85 mmol, 1.1 equiv) and acetone (160 mL). The mixture wassparged with nitrogen for 15 minutes and the flask wrapped in foil toexclude light. Triethylamine (3.33 mL, 23.9 mmol, 3.0 equiv) was addedthen the reaction mixture was heated at 50° C. overnight. After 18hours, the reaction mixture was cooled to room temperature, filteredthrough a pad of Celite® (20 g) and the filtrate was concentrated underreduced pressure. The residue was triturated with 10% dichloromethane inmethanol (60 mL). The solid was filtered and washed with methanol (50mL) to give mer-complex (7.2 g, 88% HPLC purity, 87% Q NMR purity) as anorange solid.

Bis[2-(4-(methyl-d₃)phenyl-2′-yl)-4,5-bis(methyl-d₃)pyridin-1-yl][2-((dibenzo[b,d]furan-4-yl)-3′-yl)-4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)pyridin-1-yl]iridium(III)

The meridonal isomer was converted to the facial isomer viaphotoisomerization.

Purification

Crude product after photo reaction (˜8 g) was filtered through a 2 inchpad of silica gel (˜50 g) topped with a 6 inch pad of basic alumina(˜200 g), eluting with 50% dichloromethane in hexanes (1 L). Productfractions were concentrated under reduced pressure. The residue wasdissolved in dichloromethane, adsorbed onto Celite® (14.7 g) andpurified on a Biotage Isolera automated chromatography system (3 stacked100 g Biotage HC silica gel cartridges), eluting with 0-17%tetrahydrofuran in hexanes. Pure product fractions were concentratedunder reduced pressure. The residue was dissolved dichloromethane (20mL) and precipitated with methanol (50 mL). The solid was filtered andwashed with methanol (30 mL) to givebis[2-(4-(methyl-d₃)phenyl-2′-yl)-4,5-bis(methyl-d₃)-pyridin-1-yl][2-((dibenzo[b,d]furan-4-yl)-3′-yl)-4-(4-(2,2-di-methylpropyl-1,1-d₂)-phenyl)pyridin-1-yl]iridium(III)(2.9 g, 36% yield, 99.8% UPLC purity) as a bright yellow solid.

SYNTHESIS EXAMPLE 5

[Ir(4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phenyl)pyridine(-1H))₂(MeOH)₂](tri-fluoromethanesulfonate)

To a solution of di-μ-chloro-tetrakis[κ2(C2,N)-4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)-phenyl)pyridine]diiridium(III)(106 g 122 mmol, 1.0 equiv) in dichloromethane (2.0 L) was added asolution of silver trifluoromethanesulfonate (69.3 g, 270 mmol, 2.2equiv) in methanol (500 mL) added. The flask was wrapped with foil toexclude light then the reaction mixture was stirred overnight at roomtemperature under nitrogen. The reaction mixture was filtered through apad of silica gel (300 g) topped with Celite® (20 g), rinsing withdichloromethane (1.0 L). The filtrate was concentrated under reducedpressure and the residue dried in a vacuum oven to give[Ir(4,5-bis(methyl-d₃)-2-(4-(methyl-d₃) phenyl)pyridine(-1H))₂-(MeOH)₂]trifluoromethanesulfonate (˜162.5 g, 81% yield) as a yellow solid.

mer-bis[4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phen-2′-yl)pyridin-1-yl]-[4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-((naphtho[1,2-b]benzofuran-10-yl)-9′-yl)pyridin-1-yl]Iridium(III)

A 250 mL, 4-neck flask was charged with[Ir(4,5-bis(methyl-d₃)-2-(4-(methyl-d₃) phenyl)pyridine(-1H))₂-(MeOH)₂]trifluoromethanesulfonate (4.00 g, 4.90 mmol, 1.0 equiv),4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-(naphtho[1,2-b]benzofuran-10-yl)pyridine(2.40 g, 5.39 mmol, 1.1 equiv) and acetone (153 mL) then the mixture wasstirred for several minutes under a nitrogen atmosphere. Triethylamine(2.05 mL, 14.7 mmol, 3.0 equiv) was added then the reaction mixtureheated at 50° C. for 18 hours. The reaction mixture was removed fromheat and allowed to cool to room temperature. The reaction mixture wasfiltered through a pad of Celite® (5 g), rinsing with dichloromethane(1.0 L). The filtrate was concentrated to give a red-orange solid whichwas triturated with 20% dichloromethane in methanol (100 mL) at 35° C.for one hour. The suspension was cooled to room temperature, filteredand the solid rinsed with methanol (50 mL). The solid was dried in avacuum oven overnight at 50° C. to give mer-complex (4.47 g) as anorange solid.

Bis[4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phen-2′-yl)pyridin-1-yl]-[4-(4(2,2-di-methylpropyl-1,1-d₂)phenyl)-2-((naphtho[1,2-b]benzofuran-10-yl)-9′-yl)pyridin-1-yl]Iridium(III)

The meridonal isomer was converted to the facial isomer viaphotoisomerization.

Purification

Crude compound after photoreaction (˜5.0 g, wet) was filtered through a1 inch pad of basic alumina atop a 1 inch pad of silica gel (1×1 inch),eluting with dichloromethane (1.0 L). Product fractions wereconcentrated under reduced pressure to give a red-orange solid. Therecovered material was purified on a Biotage automated chromatographysystem (2 stacked 350 g silica gel cartridges), eluting with 0-30%tetrahydrofuran in hexanes. Cleanest product fractions concentratedunder reduced pressure. The solid was precipitated from dichloromethane(50 mL) with methanol (50 mL) to give, after drying in a vacuum ovenovernight at 50° C.,bis[4,5-bis(methyl-d₃)-2-(4-(methyl-d₃)phen-2′-yl)pyridin-1-yl][4-(4-(2,2-dimethylpropyl-1,1-d₂)phenyl)-2-((naphtho[1,2-b]benzo-furan-10-yl)-9′-yl)pyridin-1-yl]Iridium(III)(2.63 g, 51% yield, 99.5% UPLC purity) as an orange solid.

Device Fabrications

All device examples were fabricated by high vacuum (<10⁻⁷ Torr) thermalevaporation (VTE). The anode electrode was 800 Å of indium tin oxide(ITO). The cathode consisted of 10 Å of LiQ (8-quinolinolato lithium)followed by 1000 Å of Al. All devices were encapsulated with a glass lidsealed with an epoxy resin in a nitrogen glove box (<1 ppm of H₂O andO₂) immediately after fabrication, and a moisture getter wasincorporated inside the package.

The organic stack of the device examples consisted of sequentially, fromthe ITO surface, 100 Å of HATCN as the hole injection layer (HIL), 450 Åof hole transport material HTM as the hole transport layer (HTL), 50 Åof EBL as an electron blocking layer (EBL), 400 Å of 10 to 15 wt %emitter doped in a host as the emissive layer (EML) wherein the hostcomprised a 60/40 wt % mixture of H1/H2, and 350 Å of 35% ETM in LiQ asthe electron transport layer (ETL). As used herein, HATCN, HTM, EBL, H1,H2, and ETM have the following structures. Device structure is shown inthe Table 1, and the chemical structures of the device materials areshown below.

TABLE 1 Device example layer structure Layer Material Thickness [Å]Anode ITO 1,150 HIL HAT-CN 100 HTL HTM 450 EBL EBL 50 EML H1/H2 (6:4):Emitter (wt % as 400 noted in Table 2) ETL Liq: ETM 35% 350 EIL Liq 10Cathode Al 1,000

TABLE 2 Device Performance of Inventive Examples (YD) vs ComparisonExamples (CE) Maximum At 1,000 nits (nm) FWHM EQE LE Example Emitter wt% Wavelength [nm] (%) [cd/A] Example 1 YD1 15 557 62 30.4 106.5 Example2 CE1 15 565 75 28.0  88.7 Example 3 YD2 12 553 72 28.9 102.2 Example 4CE2 12 566 84 26.6  82.4

It can be seen from the device data in Table 2 that inventive emittercompounds (YD1 and YD2) both exhited better EQE, and higher luminanceefficacy (LE) than their counterpart comparative compounds (CE1 and CE2)under same device testing conditions. The inventive emitter compoundswere more efficient than their comparative compounds. In addition, theFWHM of YD1 (62 nm) and YD2 (72 nm) are narrower than the comparisoncompounds CE1 (75 nm) and CE2 (84 nm), respectively, which is apreferred property for emitters. The device performance of inventivecompounds (YD) was unexpectedly superior to the comparison compounds(CE). These observed improvements were significant and beyond any valuethat could be attributed to experimental error.

1. A compound, Ir(L_(A))_(m)(L_(B))_(3-m), having a structure of FormulaI,

wherein each of moiety A and moiety C is independently a 5-memberedcarbocyclic or heterocyclic ring, a 6-membered carbocyclic orheterocyclic ring, or a polycyclic fused ring system comprising5-membered and/or 6-membered carbocyclic or heterocyclic rings; moiety Bis a 5-membered heterocyclic ring; Z¹, Z², and Z³ are each independentlyC or N; m is 1 or 2; R^(A), R^(B), and R^(C) each independentlyrepresent mono to the maximum allowable substitution, or nosubstitution; at least one of R¹, R², R³, R⁴ has a structure of FormulaII,

or is a 5-membered heterocyclic ring; X¹ is CR^(1a) or N, X² is CR^(2a)or N, X³ is CR^(3a) or N, X⁴ is CR^(4a) or N, and X⁵ is CR^(5a) or N;each of R¹, R², R³, R⁴, R^(A), R^(B), R^(C), R^(1a), R^(2a), R^(3a),R^(4a), and R^(5a) is independently hydrogen or a substituent selectedfrom the group consisting of deuterium, halogen, alkyl, cycloalkyl,heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino,germyl, selenyl, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl,aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile,isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinationsthereof; at least one of R^(1a), R^(2a), R^(3a), R^(4a), R^(5a) isselected from the group consisting of cycloalkyl, alkyl, silyl, germyl,partially or fully deuterated variants thereof, partially or fullyfluorinated variants thereof, and combinations thereof; if R³ hasFormula II, R^(3a) is alkyl, and each of R^(1a), R^(2a), R^(4a), andR^(5a) is H, then R^(3a) is partially or fully deuterated or R^(3a)comprises at least four carbon atoms; and wherein any two substituentsmay be joined or fused to form a ring, with the provisos that R^(1a),R^(2a), R^(3a), R^(4a), and R^(5a) do not form a 6-membered ring.
 2. Thecompound of claim 1, wherein each of R¹, R², R³, R⁴, R^(A), R^(B),R^(C), R^(1a), R^(2a), R^(3a), R^(4a), and R^(5a) is independentlyhydrogen or a substituent selected from the group consisting ofdeuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy,amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl,heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3.The compound of claim 1, wherein moiety A is a 5-membered and/or6-membered carbocyclic or heterocyclic ring, or a polycyclic fused ringsystem comprising a total of at least two, at least three, or at leastfour 5-membered and/or 6-membered carbocyclic or heterocyclic rings;and/or wherein moiety C is selected from the group consisting ofbenzene, pyridine, pyrimidine, pyridazine, pyrazine, triazine,imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole,naphthalene, quinoline, isoquinoline, quinazoline, benzofuran,benzoxazole, benzothiophene, benzothiazole, benzoselenophene, indene,indole, benzimidazole, carbazole, dibenzofuran, dibenzothiophene,quinoxaline, phthalazine, phenanthrene, phenanthridine, and fluorene. 4.The compound of claim 1, wherein moiety B is imidazole and Z¹ is N;and/or wherein two R^(B) are joined or fused to form a 5-membered and/or6-membered aryl or heteroaryl ring; and/or wherein R^(B) is selectedfrom the group consisting of aryl, alkyl, and combinations thereof. 5.The compound of claim 1, wherein R¹ is a 5-membered heterocyclic ring;and/or wherein R² is a 5-membered heterocyclic ring; and/or wherein R³is a 5-membered heterocyclic ring; and/or wherein R⁴ is a 5-memberedheterocyclic ring; and/or wherein exactly one of R¹, R², R³, and R⁴ is a5-membered heterocyclic ring.
 6. The compound of claim 1, wherein R¹ hasa structure of Formula II; and/or wherein R² has a structure of FormulaII; and/or wherein R³ has a structure of Formula II; and/or wherein R⁴has a structure of Formula II; and/or wherein exactly one of R², R³, andR⁴ has a structure of Formula II; and/or wherein more than one of R¹,R², R³, R⁴ has a structure of Formula II or is a 5-membered heterocyclicring; and/or wherein none of X¹ to X⁵ are N; or at least one of X¹ to X⁵is N, or exactly one of X¹ to X⁵ is N.
 7. The compound of claim 6,wherein each of R^(1a), R^(2a), R^(3a), R^(4a), R^(5a) is independentlyselected from the group consisting of cycloalkyl, alkyl, silyl, germyl,partially or fully deuterated variants thereof, partially or fullyfluorinated variants thereof, and combinations thereof.
 8. The compoundof claim 6, wherein at least one of R^(1a), R^(2a), R^(3a), R^(4a), andR^(5a) is independently hydrogen or a substituent selected from thegroup consisting of:


9. The compound of claim 1, wherein the ligand L_(A) is selected fromthe group consisting of:

wherein ring B1 is a 5-membered aryl or heteroaryl group, or a6-memerbed aryl or heteroaryl group; wherein R^(B1) represents mono tothe maximum allowable substitution, or no substitution; each R^(B1) andR^(B2) is independently hydrogen or a substituent selected from thegroup consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl,heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, germyl,selenyl, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl,heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile,sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;moiety C is selected from the group consisting of benzene, pyridine,pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole,pyrrole, oxazole, furan, thiophene, thiazole, naphthalene, quinoline,isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene,benzothiazole, benzoselenophene, indene, indole, benzimidazole,carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine,phenanthrene, phenanthridine, and fluorene; and two adjacent R^(B),R^(B1), or R^(C) can be joined to form a ring.
 10. The compound of claim1, wherein the ligand L_(A) is selected from the group consisting of:

wherein X¹⁰, X¹¹, X¹², X¹³, X¹⁴, X¹⁵, X¹⁶, X¹⁷, X¹⁸, and X¹⁹ are eachindependently C or N; Y¹⁰⁰ for each occurrence is independently selectedfrom the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO₂, CRR′,SiRR′, and GeRR′; R^(C1) represents mono to the maximum allowablesubstitution, or no substitution; each R^(C1) is independently hydrogenor a substituent selected from the group consisting of deuterium,halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl,alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl,heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether,ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino,boryl, selenyl, and combinations thereof; R, and R′ are eachindependently hydrogen or a substituent selected from the groupconsisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl,heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl,boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl,acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl,sulfinyl, sulfonyl, phosphino, boryl, selenyl, and combinations thereof;and two adjacent R^(B), R^(B1), R^(C), or R^(C1) can be joined to form aring; wherein ring B1 is selected from the group consisting of benzene,pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole,pyrazole, pyrrole, oxazole, furan, thiophene, and thiazole; and R^(B2)is selected from the group consisting of alkyl, cycloalkyl, aryl,heteroaryl, their partially or fully deuterated or partially or fullyfluorinated counterparts, and combinations thereof.
 11. The compound ofclaim 1, wherein the ligand L_(A) is L_(Ai), wherein i is an integerfrom 1 to 100, and L_(A1) to L_(A100) have the following structures:


12. The compound of claim 1, wherein ligand L_(B) is selected from thegroup consisting of:

wherein: R^(2b) and R^(3b) each independently represents mono to themaximum allowable substitution, or no substitution; Z₁ and Z₂ are eachindependently C or N; each of R^(1′), R^(2′), R^(3′), R^(4′), R^(2b),and R^(3b) is independently hydrogen or a substituent selected from thegroup consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl,heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, germyl,selenyl, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl,heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile,sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;moiety A is selected from the group consisting of benzene, pyridine,pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole,pyrrole, oxazole, furan, thiophene, thiazole, naphthalene, quinoline,isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene,benzothiazole, benzoselenophene, indene, indole, benzimidazole,carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine,phenanthrene, phenanthridine, and fluorene; and two adjacent R^(1′),R^(2′), R^(3′), R^(4′), R^(2b) or R^(3b) can be joined to form a ring.13. The compound of claim 1, wherein the ligand L_(B) is selected fromthe group consisting of:

wherein: R^(A), R_(A1), R^(2b), and R^(3b) each independently representmono to the maximum allowable substitution, or no substitution; X isselected from the group consisting of BR_(e), NR_(e), PR_(e), O, S, Se,C═O, S═O, SO₂, CR_(e)R_(f), SiR_(e)R_(f), and GeR_(e)R_(f); each ofR^(A), R^(A1), R^(2b), R^(3b), R_(e) and R_(f) is independently hydrogenor a substituent selected from the group consisting of deuterium,halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl,arylalkyl, alkoxy, aryloxy, amino, germyl, selenyl, silyl, alkenyl,cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylicacid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl,phosphino, and combinations thereof; and two of R^(A), R^(A1), R^(2b),R^(3b), R_(e), and R_(f) can be fused or joined to form a ring.
 14. Thecompound claim 1, wherein the ligand L_(B) is L_(Bn), wherein n is aninteger from 1 to 151, and L_(B1) to L_(B151) have the followingstructures:


15. The compound of claim 1, wherein the compound has FormulaIr(L_(Ai))(L_(Bn))₂, or Formula Ir(L_(Ai))₂(L_(Bn)), wherein i is aninteger from 1 to 100, and n is an integer from 1 to 151, and L_(A1) toL_(A100) have the following structures:

and L_(B1) to L_(B151) have the following structures:


16. The compound of claim 1, wherein the compound is selected from thegroup consisting of:


17. An organic light emitting device (OLED) comprising: an anode; acathode; and an organic layer disposed between the anode and thecathode, wherein the organic layer comprises a compound,Ir(L_(A))_(m)(L_(B))_(3-m), having a structure of Formula I,

wherein each of moiety A and moiety C is independently a 5-memberedcarbocyclic or heterocyclic ring, a 6-membered carbocyclic orheterocyclic ring, or a polycyclic fused ring system comprising5-membered and/or 6-membered carbocyclic or heterocyclic rings; moiety Bis a 5-membered heterocyclic ring; Z¹, Z², and Z³ are each independentlyC or N; m is 1 or 2; R^(A), R^(B), and R^(C) each independentlyrepresent mono to the maximum allowable substitution, or nosubstitution; at least one of R¹, R², R³, R⁴ has a structure of FormulaII,

or is a 5-membered heterocyclic ring; X¹ is CR^(1a) or N, X² is CR^(2a)or N, X³ is CR^(3a) or N, X⁴ is CR^(4a) or N, and X⁵ is CR^(5a) or N;each of R¹, R², R³, R⁴, R^(A), R^(B), R^(C), R^(1a), R^(2a), R^(3a),R^(4a), and R^(5a) is independently hydrogen or a substituent selectedfrom the group consisting of deuterium, halogen, alkyl, cycloalkyl,heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino,germyl, selenyl, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl,aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile,isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinationsthereof; at least one of R^(1a), R^(2a), R^(3a), R^(4a), R^(5a) isselected from the group consisting of cycloalkyl, alkyl, silyl, germyl,partially or fully deuterated variants thereof, partially or fullyfluorinated variants thereof, and combinations thereof; if R³ hasFormula II, R^(3a) is alkyl, and each of R^(1a), R^(2a), R^(4a), andR^(5a) is H, then R^(3a) is partially or fully deuterated or R^(3a)comprises at least four carbon atoms; and wherein any two substituentsmay be joined or fused to form a ring, with the provisos that R^(1a),R^(2a), R^(3a), R^(4a), and R^(5a) do not form a 6-membered ring. 18.The OLED of claim 17, wherein the organic layer further comprises ahost, wherein host comprises at least one chemical moiety selected fromthe group consisting of triphenylene, carbazole, indolocarbazole,dibenzothiphene, dibenzofuran, dibenzoselenophene,5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, aza-triphenylene,aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene,aza-dibenzofuran, aza-dibenzoselenophene, andaza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).
 19. The OLED ofclaim 18, wherein the host is selected from the group consisting of:

and combinations thereof.
 20. A consumer product comprising an organiclight-emitting device OLED comprising: an anode; a cathode; and anorganic layer disposed between the anode and the cathode, wherein theorganic layer comprises a compound, Ir(L_(A))_(m)(L_(B))_(3-m), having astructure of Formula I,

wherein each of moiety A and moiety C is independently a 5-memberedcarbocyclic or heterocyclic ring, a 6-membered carbocyclic orheterocyclic ring, or a polycyclic fused ring system comprising5-membered and/or 6-membered carbocyclic or heterocyclic rings; moiety Bis a 5-membered heterocyclic ring; Z¹, Z², and Z³ are each independentlyC or N; m is 1 or 2; R^(A), R^(B), and R^(C) each independentlyrepresent mono to the maximum allowable substitution, or nosubstitution; at least one of R¹, R², R³, R⁴ has a structure of FormulaII,

or is a 5-membered heterocyclic ring; X¹ is CR^(1a) or N, X² is CR^(2a)or N, X³ is CR^(3a) or N, X⁴ is CR^(4a) or N, and X⁵ is CR^(5a) or N;each of R¹, R², R³, R⁴, R^(A), R^(B), R^(C), R^(1a), R^(2a), R^(3a),R^(4a), and R^(5a) is independently hydrogen or a substituent selectedfrom the group consisting of deuterium, halogen, alkyl, cycloalkyl,heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino,germyl, selenyl, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl,aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile,isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinationsthereof; at least one of R^(1a), R^(2a), R^(3a), R^(4a), R^(5a) isselected from the group consisting of cycloalkyl, alkyl, silyl, germyl,partially or fully deuterated variants thereof, partially or fullyfluorinated variants thereof, and combinations thereof; if R³ hasFormula II, R^(3a) is alkyl, and each of R^(1a), R^(2a), R^(4a), andR^(5a) is H, then R^(3a) is partially or fully deuterated or R^(3a)comprises at least four carbon atoms; and wherein any two substituentsmay be joined or fused to form a ring, with the provisos that R^(1a),R^(2a), R^(3a), R^(4a), and R^(5a) do not form a 6-membered ring.